No definition available.
Purpura and other haemorrhagic conditions
DOID EFO Endpoint Browser PheWeb
D3_PURPURA_AND3_OTHER_HAEMORRHAGIC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
4949 |
4. Check minimum number of eventsNone |
4949 |
5. Include endpoints |
5538 |
6. Filter based on genotype QC (FinnGen only) |
5538 |
Control definitions (FinnGen only)
- Control exclude
- D3_COAGDEF_PURPUR_HAEMORRHAGIC
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D65-D69
- Name in latin
- Purpura et alii status haemorrhagici
Similar endpoints
↥List of similar endpoints to
Purpura and other haemorrhagic conditions
based on the number of shared cases.
Similar with more cases:
- Coagulation defects, purpura and other haemorrhagic conditions
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 46359 | 22834 | 23162 |
| Only index persons | 38984 | 19590 | 19394 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.65 | 0.65 | 0.65 |
| Only index persons | 0.73 | 0.72 | 0.74 |
| Median age at first event (years) | |||
| Whole population | 53.17 | 52.56 | 53.62 |
| Only index persons | 51.14 | 49.94 | 52.35 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5538 | 2920 | 2618 |
| Unadjusted period prevalence (%) | 1.07 | 1.00 | 1.15 |
| Median age at first event (years) | 55.98 | 50.14 | 62.50 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 4997
- Matched controls
- 49969
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D69.0
ICD-10 Finland
Allergic purpura
625.3
323.0
794
15
WW500
NOMESCO Finland
Blood transfusion
10.1
323.0
700
795
XW000
NOMESCO Finland
Bone marrow biopsy
14.9
323.0
954
777
D69.9
ICD-10 Finland
Haemorrhagic condition, unspecified
245.9
323.0
448
20
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
986.7
323.0
2289
42
D69.5
ICD-10 Finland
Secondary thrombocytopenia
991.2
323.0
368
*
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
10803.2
323.0
901
*
D69.2
ICD-10 Finland
Other nonthrombocytopenic purpura
351.8
268.4
269
8
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
8.0
252.3
609
848
H02AB06
ATC
prednisolone; systemic
2.6
214.9
2754
16191
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
308.9
203.9
206
7
D64.9
ICD-10 Finland
Anaemia, unspecified
4.0
201.7
908
2603
D70.82
ICD-10 Finland
Drug-induced neutropenia
15.0
200.7
345
246
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.4
186.2
1059
3662
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
169.7
2445
14574
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.6
167.7
866
2754
28700
ICD-8 Finland
Purpura and other haemorrhagic conditions, Allergic purpura
+∞
158.1
151
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
15.8
150.6
252
167
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.7
143.9
441
831
R50.9
ICD-10 Finland
Fever, unspecified
2.9
140.4
1010
4028
ZX120
NOMESCO Finland
Intravenous
3.3
130.3
727
2419
D69.1
ICD-10 Finland
Qualitative platelet defects
644.3
128.0
126
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
126.7
1744
9769
2873A
ICD-9 Finland
Purpura and other haemorrhagic conditions, Primary thrombocytopenia[PURPURA THROMBOCYTOPENICA IDIOPATHICA (ITP)]
+∞
125.5
120
*
D69.4
ICD-10 Finland
Other primary thrombocytopenia
+∞
124.5
119
*
M04AA01
ATC
allopurinol; systemic
2.9
124.0
858
3309
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
8.3
122.7
285
363
28719
ICD-8 Finland
Purpura and other haemorrhagic conditions, Thrombocytopenia NUD
+∞
121.3
116
*
L03AA02
ATC
filgrastim; parenteral
7.2
121.2
308
450
N08.2*D69.0
ICD-10 Finland
Glomerular disorders in Henoch(-Schönlein) purpura
+∞
120.3
115
*
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
41.2
117.4
148
37
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.3
111.8
618
2025
A02BC02
ATC
pantoprazole; systemic
2.0
110.7
3201
23731
C03CA01
ATC
furosemide; systemic
2.1
109.4
1574
8855
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.5
106.6
949
4219
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.0
102.8
663
2416
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
11.1
102.3
200
187
D69.8
ICD-10 Finland
Other specified haemorrhagic conditions
67.0
102.1
118
18
JN4BD
NOMESCO Finland
Extensive body CT
2.8
100.5
728
2859
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.7
92.6
337
761
2870A
ICD-9 Finland
Purpura and other haemorrhagic conditions, Allergic purpura[PURPURA HENOCH-SCHÖNLEIN]
+∞
89.8
86
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
13.0
88.0
159
126
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
84.8
1501
8986
B02BX05
ATC
eltrombopag; oral
842.4
84.8
83
*
JN4AD
NOMESCO Finland
Body CT examination
3.1
83.5
506
1755
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.4
82.6
436
1368
A03FA01
ATC
metoclopramide; systemic, rectal
2.1
78.3
1093
5923
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
77.3
1140
6313
L03AA14
ATC
lipegfilgrastim; parenteral
7.3
77.2
192
271
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
9.5
74.8
158
171
D68.8
ICD-10 Finland
Other specified coagulation defects
44.6
74.4
92
21
J01MA12
ATC
levofloxacin; systemic
2.1
74.2
1003
5347
H02AB07
ATC
prednisone; oral
2.3
73.4
795
3835
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.2
73.0
417
1380
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
71.0
1249
7365
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
7.5
70.2
171
234
H02AB02
ATC
dexamethasone; systemic
2.6
70.2
588
2481
L04AX01
ATC
azathioprine; systemic
3.7
69.8
323
909
N02AA05
ATC
oxycodone; systemic
2.2
69.6
785
3851
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.8
68.9
240
516
L03AA13
ATC
pegfilgrastim; parenteral
4.0
66.3
278
717
D68.0
ICD-10 Finland
Von Willebrand disease
+∞
64.7
62
*
B03XA02
ATC
darbepoetin alfa; parenteral
6.3
63.4
175
286
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
61.6
1648
11069
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
8.2
60.7
139
173
A04AA01
ATC
ondansetron; systemic, rectal
2.9
60.6
397
1439
A04AA02
ATC
granisetron; systemic, transdermal
3.0
59.0
361
1252
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
57.3
490
2080
1517
Kela drug reimbursment
NA
564.3
56.7
56
*
3039
Kela drug reimbursment
NA
564.3
56.7
56
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
23.1
56.7
82
36
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.2
56.3
224
550
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
10.1
56.2
114
115
ZXE00
NOMESCO Finland
One hour or less
1.6
56.2
1931
13834
ZXD05
NOMESCO Finland
Urgent procedure
1.7
55.8
1547
10432
A41.9
ICD-10 Finland
Sepsis, unspecified
3.7
55.0
256
722
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
9.2
54.7
117
130
D69
ICD-10 Finland
Purpura and other haemorrhagic conditions
69.6
54.2
62
9
L95.8
ICD-10 Finland
Other vasculitis limited to skin
26.2
53.8
75
29
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.3
53.8
293
935
JN6AD
NOMESCO Finland
CT of torso and neck
7.3
53.6
132
184
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
15.3
53.3
89
59
B01AB10
ATC
tinzaparin; parenteral
2.7
52.8
391
1525
N02AX02
ATC
tramadol; systemic, rectal
1.6
52.3
1935
14056
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
15.2
52.0
87
58
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.8
51.8
348
1280
C83.1
ICD-10 Finland
Mantle cell lymphoma
16.9
51.6
83
50
Z51.5
ICD-10 Finland
Palliative care
2.8
50.8
354
1332
TGC00
NOMESCO Finland
Bronchial lavation
4.5
50.7
188
431
YNB10
NOMESCO Finland
Collection of stem cells for transplant
38.1
50.4
64
17
28799
ICD-8 Finland
Purpura and other haemorrhagic conditions, Other and unspecified
+∞
50.1
48
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.2
49.6
581
2867
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
32.9
49.5
65
20
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
11.7
49.0
92
80
D68.9
ICD-10 Finland
Coagulation defect, unspecified
56.6
47.5
56
10
L04AD01
ATC
ciclosporin; systemic
4.8
47.4
163
346
TK800
NOMESCO Finland
Hemodialysis
4.6
47.4
171
382
C03DA01
ATC
spironolactone; oral
2.2
47.1
552
2723
2875A
ICD-9 Finland
Purpura and other haemorrhagic conditions, Thrombocytopenia, unspecified
+∞
46.9
45
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.0
46.6
290
1014
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.9
46.6
746
4170
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
46.6
1014
6293
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
19.4
46.6
71
37
R04.0
ICD-10 Finland
Epistaxis
2.5
46.2
402
1714
B01AB05
ATC
enoxaparin; parenteral
1.6
46.1
1370
9307
L04AA06
ATC
mycophenolic acid; systemic
5.2
45.8
148
294
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
8.0
45.5
105
133
J01DB01
ATC
cefalexin; oral
1.6
45.0
3860
33834
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.4
44.4
231
712
ZX108
NOMESCO Finland
Inhalation
10.2
44.2
89
89
I50.9
ICD-10 Finland
Heart failure, unspecified
2.0
44.2
651
3523
B01AA03
ATC
warfarin; systemic
1.8
43.6
944
5832
A02BC01
ATC
omeprazole; systemic
1.6
43.5
1283
8674
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
43.2
1269
8567
E0000UV
ATC
NA
1.6
42.9
1808
13371
M36.4*D69.0
ICD-10 Finland
Arthropathy in Henoch(-Schönlein) purpura
+∞
42.8
41
*
AA1AD
NOMESCO Finland
CT of head and brain
1.7
42.4
1081
7011
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.7
42.3
311
1206
A46
ICD-10 Finland
Erysipelas
1.9
42.1
681
3808
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.6
42.0
331
1338
1XC02
NOMESCO Finland
NA
9.2
42.0
89
98
127
Kela drug reimbursment
Transplant complication
5.1
41.7
135
269
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
41.5
827
4968
6BA02
NOMESCO Finland
NA
16.2
41.2
67
42
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
21.7
40.9
60
28
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.3
40.2
127
246
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
5.6
39.8
120
220
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
5.5
39.1
118
217
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
38.7
2311
18330
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.5
37.0
315
1325
JN3AD
NOMESCO Finland
Abdominal CT examination
2.3
36.6
377
1747
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
36.5
382
1782
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.0
36.5
151
386
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.2
36.4
388
1825
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
36.3
797
4914
D07AC01
ATC
betamethasone; topical
1.5
36.0
1509
11028
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
36.0
501
2640
J01FF01
ATC
clindamycin; systemic
1.6
35.9
1197
8284
B02AA02
ATC
tranexamic acid; systemic
1.8
35.7
627
3596
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
7.3
35.6
87
121
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
35.2
1632
12186
R23.3
ICD-10 Finland
Spontaneous ecchymoses
4.3
35.2
136
326
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
7.5
35.2
84
113
J01MA02
ATC
ciprofloxacin; systemic
1.5
34.9
1724
13046
WX892
NOMESCO Finland
Monitored bed care
2.2
34.7
386
1851
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.9
34.7
535
2931
28710
ICD-8 Finland
Purpura and other haemorrhagic conditions, Thrombocytopenia essentialis (Morbus Werlhof)
+∞
34.4
33
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.0
34.4
506
2722
R18
ICD-10 Finland
Ascites
4.5
34.3
125
283
J01MA14
ATC
moxifloxacin; systemic
2.1
33.5
419
2112
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
3.2
33.4
184
592
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
5.0
33.1
109
222
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
33.1
664
3971
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
10.8
33.1
64
60
Z3231
NOMESCO Finland
Registered nurse
1.5
32.9
1284
9193
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
32.9
1563
11691
Z2221
NOMESCO Finland
Medical doctor
1.5
32.9
1282
9176
D07AB08
ATC
desonide; topical
1.9
32.8
508
2782
D61.9
ICD-10 Finland
Aplastic anaemia, unspecified
31.0
32.5
43
14
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
9.7
32.2
66
69
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.7
32.2
786
4988
J05AB11
ATC
valaciclovir; oral
1.8
32.1
595
3468
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
8.5
32.1
71
85
H02AB09
ATC
hydrocortisone; systemic
3.5
32.0
155
453
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.2
32.0
357
1711
N02BE01
ATC
paracetamol; systemic, rectal
1.5
32.0
3950
35625
R4110
NOMESCO Finland
Physiotherapy
1.5
31.8
1181
8347
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.6
31.5
981
6643
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
14.5
31.4
53
37
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
10.3
31.3
62
61
M05BA04
ATC
alendronic acid; oral
2.1
31.1
376
1867
UJF32
NOMESCO Finland
Coloscopy
1.5
30.8
1131
7963
P01BA02
ATC
hydroxychloroquine; oral
2.1
30.6
379
1901
WW200
NOMESCO Finland
Immunization
3.2
30.5
164
519
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.0
30.5
438
2330
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
4.9
30.2
101
210
C07AB07
ATC
bisoprolol; oral
1.4
30.1
1999
15911
K92.1
ICD-10 Finland
Melaena
2.4
30.0
268
1156
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.0
30.0
183
631
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
4.6
29.9
106
234
6753
FHL
Transabdominal splenectomy
34.8
29.6
38
11
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.1
29.6
365
1827
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
4.7
29.5
102
220
N03AX16
ATC
pregabalin; oral
1.6
29.0
982
6772
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.8
28.9
595
3578
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.6
28.9
133
374
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.8
28.8
192
702
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
6.5
28.8
76
119
WZC30
NOMESCO Finland
Teaching
1.8
28.8
589
3539
JMA10
NOMESCO Finland
Transabdominal total splenectomy
7.8
28.4
66
86
ZX112
NOMESCO Finland
Subcutaneous
3.5
28.1
137
403
B02BX04
ATC
romiplostim; parenteral
+∞
28.1
27
*
9673/3-C42.1
ICD-O-3
Mantle cell lymphoma of bone marrow
55.3
28.1
33
6
R53
ICD-10 Finland
Malaise and fatigue
1.6
28.1
895
6072
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
28.0
747
4839
126
Kela drug reimbursment
Chronic coagulation defects
283.0
27.8
28
*
R60.0
ICD-10 Finland
Localized oedema
1.8
27.4
488
2799
J04BA02
ATC
dapsone; oral
9.6
27.3
56
59
PJA10
NOMESCO Finland
Exploration of lymph nodes
5.5
27.2
82
152
122
Kela drug reimbursment
Aplastic anaemia
53.6
27.2
32
6
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.6
27.0
127
364
Z3226
NOMESCO Finland
Physiotherapist
1.6
26.9
826
5546
A06AD11
ATC
lactulose; oral
1.7
26.8
640
4020
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
5.8
26.8
77
135
L81.7
ICD-10 Finland
Pigmented purpuric dermatosis
12.8
26.5
47
37
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
26.5
897
6163
M10.9
ICD-10 Finland
Gout, unspecified
2.1
26.5
300
1447
D73.1
ICD-10 Finland
Hypersplenism
34.2
26.5
34
10
Z49.1
ICD-10 Finland
Extracorporeal dialysis
4.6
26.5
94
209
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.3
26.3
138
430
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.3
26.1
247
1098
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
26.0
767
5094
R31
ICD-10 Finland
Unspecified haematuria
1.8
25.7
455
2605
D61.3
ICD-10 Finland
Idiopathic aplastic anaemia
93.9
25.7
28
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
25.7
1766
14024
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.2
25.6
260
1194
J01CA04
ATC
amoxicillin; systemic
1.4
25.6
3725
33635
N18.8
ICD-10 Finland
Other chronic renal failure
2.9
25.6
156
541
WX002
NOMESCO Finland
Sedation and analgesia
1.6
25.3
846
5790
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.2
25.1
138
446
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.8
25.0
166
607
Z2446
NOMESCO Finland
Social worker
2.0
25.0
320
1626
L01CB01
ATC
etoposide; systemic
8.7
24.9
54
63
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.1
24.9
138
448
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.3
24.9
245
1110
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.9
24.7
405
2256
N05CF01
ATC
zopiclone; oral
1.4
24.6
1357
10329
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
11.6
24.4
45
39
XX3DW
NOMESCO Finland
Time consuming IT work
1.8
24.4
449
2603
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
24.3
916
6441
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
14.2
24.3
41
29
S97
ICPC
Chronic ulcer skin
2.2
24.0
249
1155
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
24.0
1672
13264
A41.8
ICD-10 Finland
Other specified sepsis
3.8
23.9
102
270
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.4
23.9
116
342
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
4.2
23.9
93
227
R06AE07
ATC
cetirizine; oral
1.4
23.7
1833
14793
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
10.8
23.5
45
42
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
11.7
23.4
43
37
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.8
23.3
406
2308
R06.0
ICD-10 Finland
Dyspnoea
1.5
23.3
1040
7573
J01AA02
ATC
doxycycline; systemic
1.4
23.3
3413
30522
P01AB01
ATC
metronidazole; oral, rectal
1.4
23.2
1610
12743
J01DA01
ATC
[U] cefalexin; systemic
1.3
23.0
2746
23735
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.8
22.9
419
2423
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
11.1
22.8
43
39
H02AB04
ATC
methylprednisolone; systemic
1.6
22.7
613
3972
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
22.6
1906
15571
N19
ICD-10 Finland
Unspecified kidney failure
2.6
22.6
164
634
GD1AD
NOMESCO Finland
Thorax CT examination
2.3
22.3
211
939
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
16.8
22.2
35
21
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.7
22.1
153
575
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.0
22.1
306
1603
A11CC03
ATC
alfacalcidol; systemic
3.0
22.1
132
450
1516
Kela drug reimbursment
NA
+∞
21.9
21
*
3038
Kela drug reimbursment
NA
+∞
21.9
21
*
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
21.8
1531
12111
A07AA11
ATC
rifaximin; oral
17.1
21.7
34
20
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
21.7
863
6122
ED1AA
NOMESCO Finland
Mandipular X-ray examination
6.4
21.6
57
90
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.3
21.5
203
901
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.5
21.3
166
668
JN4CD
NOMESCO Finland
Very extensive body CT
2.4
21.3
181
762
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
5.8
21.1
60
105
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
6.6
20.9
54
83
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
20.8
572
3716
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.0
20.7
279
1445
B03XA01
ATC
erythropoietin; parenteral
5.1
20.7
66
132
Z94.0
ICD-10 Finland
Kidney transplant status
4.2
20.5
78
187
TAB00
NOMESCO Finland
Lumbar puncture
2.3
20.5
201
909
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
20.3
670
4551
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
22.4
20.3
29
13
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
20.3
441
2684
A28
ICPC
Limited function/disability NOS
1.6
20.3
613
4078
L95.0
ICD-10 Finland
Livedoid vasculitis
32.7
20.2
26
8
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.0
20.2
283
1491
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
20.1
1186
9073
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
6.7
20.1
51
77
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
3.6
19.9
92
262
L04AA01
ATC
[U] ciclosporin; systemic
3.5
19.9
95
278
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
4.0
19.8
80
203
J05AB01
ATC
aciclovir; systemic
1.5
19.7
839
6026
L01AA01
ATC
cyclophosphamide; systemic
9.0
19.5
41
46
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
9.8
19.5
39
40
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
7.2
19.5
47
66
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
4.8
19.5
65
137
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.7
19.5
138
528
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
19.4
507
3248
WX110
NOMESCO Finland
Local anesthesy
1.3
19.2
3018
26811
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.8
19.2
338
1930
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
19.2
532
3463
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
4.6
19.0
66
145
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.7
19.0
375
2219
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.2
19.0
197
917
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
18.9
1803
14893
28711
ICD-8 Finland
Purpura and other haemorrhagic conditions, Thrombocytopenia symptomatica
+∞
18.8
18
*
A05AA02
ATC
ursodeoxycholic acid; oral
3.3
18.7
94
287
UKC02
NOMESCO Finland
Cystoscopy
1.5
18.7
666
4602
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.3
18.6
176
785
UJF30
NOMESCO Finland
Ileoscopy through colon
1.7
18.6
390
2351
D68.3
ICD-10 Finland
Haemorrhagic disorder due to circulating anticoagulants
100.4
18.6
20
*
ZXA00
NOMESCO Finland
Right side
1.4
18.4
1097
8392
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
12.9
18.4
32
25
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
30.1
18.3
24
8
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
4.0
18.3
73
184
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
4.7
18.2
62
134
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
2.1
18.1
218
1079
N18.0
ICD-10 Finland
End-stage renal disease
4.0
18.1
72
181
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
4.1
18.0
70
172
I50.0
ICD-10 Finland
Congestive heart failure
1.8
17.9
297
1662
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.9
17.8
278
1524
J02AC03
ATC
voriconazole; systemic
11.9
17.8
32
27
2872B
ICD-9 Finland
Purpura and other haemorrhagic conditions, Other nonthrombocytopenic purpuras
+∞
17.7
17
*
212
Kela drug reimbursment
Gout
2.9
17.7
107
369
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
10.4
17.6
34
33
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
9.8
17.6
35
36
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
14.6
17.6
29
20
WF049
NOMESCO Finland
Radiotherapy of metastasis
2.4
17.5
149
630
E87.5
ICD-10 Finland
Hyperkalaemia
3.4
17.5
84
248
ZXA05
NOMESCO Finland
Left side
1.4
17.4
1036
7910
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
4.4
17.3
62
141
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.7
17.3
359
2157
C07AG02
ATC
carvedilol; oral
1.9
17.2
254
1364
A12AA04
ATC
calcium carbonate; oral
3.2
17.2
90
284
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.4
17.1
906
6770
A02BC05
ATC
esomeprazole; systemic
1.3
17.1
1606
13181
K92.0
ICD-10 Finland
Haematemesis
2.8
17.0
113
415
C90.0
ICD-10 Finland
Multiple myeloma
4.1
17.0
66
163
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.9
16.9
103
358
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.2
16.9
177
827
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
13.2
16.9
29
22
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
3.6
16.9
77
218
ZX131
NOMESCO Finland
Intrathecal
17.4
16.9
26
15
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.7
16.8
327
1926
TQW80
NOMESCO Finland
Local dermatologic skincare
2.6
16.7
125
494
A12BA01
ATC
potassium chloride; oral
2.1
16.7
199
982
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.3
16.7
160
717
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
16.7
1189
9344
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
16.7
708
5069
K72.9
ICD-10 Finland
Hepatic failure, unspecified
6.4
16.5
43
68
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.0
16.5
223
1158
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
11.6
16.5
30
26
A07AA02
ATC
nystatin; oral
1.9
16.4
259
1425
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
4.5
16.2
57
128
XF600
NOMESCO Finland
Bloodpressure measurement
1.8
16.1
279
1584
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
6.0
16.1
44
74
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
3.2
16.1
83
259
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
12.8
16.1
28
22
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
7.0
16.1
39
56
A10AE04
ATC
insulin glargine; parenteral
1.7
16.1
372
2304
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
16.0
294
1702
E000001
ATC
NA
1.4
16.0
855
6395
WX872
NOMESCO Finland
Intensive care
2.0
15.9
209
1075
B03BA03
ATC
hydroxocobalamin; parenteral
1.9
15.9
231
1232
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
3.9
15.9
66
173
A07AA09
ATC
vancomycin; oral
3.7
15.9
69
188
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
12.2
15.8
28
23
WW409
NOMESCO Finland
Other aferesis
9.7
15.6
31
32
S18
ICPC
Laceration/cut
1.3
15.5
1705
14258
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
15.4
732
5356
ZX070
NOMESCO Finland
Intensity modified radiotherapy
2.7
15.3
104
389
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
7.7
15.3
35
46
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.5
15.2
118
476
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.0
15.2
88
297
D59.9
ICD-10 Finland
Acquired haemolytic anaemia, unspecified
11.3
15.2
28
25
WX402
NOMESCO Finland
General anaesthesia
1.5
15.2
662
4756
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
2.4
15.2
124
514
R11
ICD-10 Finland
Nausea and vomiting
1.7
15.2
336
2055
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
10.4
15.2
29
28
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.7
15.1
298
1760
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
4.2
15.1
56
133
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.1
15.1
174
851
3AC01
NOMESCO Finland
NA
3.9
15.1
62
162
J01FA06
ATC
roxithromycin; oral
1.3
15.0
1615
13452
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.6
14.9
365
2298
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
4.5
14.8
52
117
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
2.9
14.8
88
304
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
14.8
1052
8245
9680/3-C42.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of bone marrow
31.8
14.8
19
6
TKC20
NOMESCO Finland
Catheterisation of bladder
1.7
14.8
288
1697
B34.9
ICD-10 Finland
Viral infection, unspecified
2.3
14.7
130
562
C91.4
ICD-10 Finland
Hairy-cell leukaemia
25.1
14.7
20
8
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
14.7
503
3439
C08CA01
ATC
amlodipine; oral
1.3
14.6
1382
11294
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.7
14.5
306
1843
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.0
14.5
197
1028
A40.8
ICD-10 Finland
Other streptococcal sepsis
4.1
14.4
56
139
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
4.0
14.4
57
144
M13.9
ICD-10 Finland
Arthritis, unspecified
1.7
14.4
283
1673
B01AB04
ATC
dalteparin; parenteral
1.9
14.4
203
1075
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.7
14.4
323
1987
WX882
NOMESCO Finland
High dependency care
2.3
14.3
136
609
D64.8
ICD-10 Finland
Other specified anaemias
2.9
14.3
85
294
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
3.0
14.3
80
266
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
5.6
14.3
41
74
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
4.4
14.3
51
117
R60.9
ICD-10 Finland
Oedema, unspecified
2.0
14.2
191
991
L01XX05
ATC
hydroxycarbamide; oral
3.5
14.2
65
186
L28
ICPC
Limited function/disability (L)
1.5
14.2
595
4239
A02BC03
ATC
lansoprazole; oral
1.3
14.1
1128
8990
SPAT1263
SPAT
Sampling
1.3
14.1
1780
15106
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
2.1
14.0
165
815
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
3.6
13.9
63
179
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.7
13.9
295
1782
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.9
13.8
198
1052
N05BA04
ATC
oxazepam; oral
1.3
13.8
966
7538
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
6.5
13.8
35
54
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
11.4
13.8
25
22
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.9
13.7
199
1061
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
9.1
13.7
28
31
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
4.0
13.7
53
132
Z3229
NOMESCO Finland
Other healthcare associate professional
1.6
13.6
349
2220
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.8
13.6
227
1272
D68.2
ICD-10 Finland
Hereditary deficiency of other clotting factors
75.3
13.6
15
*
2879X
ICD-9 Finland
Purpura and other haemorrhagic conditions, Unspecified haemorrhagic conditions
+∞
13.5
13
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.3
13.5
128
575
K76.9
ICD-10 Finland
Liver disease, unspecified
3.3
13.4
68
211
C09AA05
ATC
ramipril; oral
1.3
13.4
939
7325
I81
ICD-10 Finland
Portal vein thrombosis
7.4
13.4
31
42
K70.1
ICD-10 Finland
Alcoholic hepatitis
5.1
13.3
41
81
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
13.3
639
4674
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
2.2
13.3
141
665
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
2.5
13.3
100
400
TPX15
NOMESCO Finland
Removal of vascular injection port
5.2
13.3
40
77
Z94.4
ICD-10 Finland
Liver transplant status
7.2
13.2
31
43
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
3.2
13.2
68
214
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
4.3
13.1
47
109
Z31.5
ICD-10 Finland
Genetic counselling
1.9
13.1
190
1016
JJC00
NOMESCO Finland
Allogenic transplantation of liver
11.0
13.0
24
22
M35.1
ICD-10 Finland
Other overlap syndromes
6.0
13.0
35
59
Z51.3
ICD-10 Finland
Blood transfusion (without reported diagnosis)
16.7
13.0
20
12
ZX121
NOMESCO Finland
Central venous catheter
5.6
12.9
37
67
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.7
12.9
258
1533
D61.0
ICD-10 Finland
Constitutional aplastic anaemia
50.1
12.8
15
*
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
6.9
12.8
31
45
N03AX14
ATC
levetiracetam; systemic
2.3
12.8
114
495
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
4.9
12.8
41
85
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
6.6
12.8
32
49
K70.4
ICD-10 Finland
Alcoholic hepatic failure
6.3
12.7
33
53
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
2.5
12.7
95
378
S29
ICPC
Skin symptom/complaint other
1.4
12.7
648
4794
D07AC13
ATC
mometasone; topical
1.3
12.7
1125
9083
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.9
12.6
196
1074
V03AE01
ATC
polystyrene sulfonate; oral
3.1
12.6
67
216
SPAT1262
SPAT
Handing over of treatment supplies
1.4
12.5
700
5258
E87.6
ICD-10 Finland
Hypokalaemia
2.2
12.5
129
603
V03AE02
ATC
sevelamer; oral
5.3
12.5
37
70
D65
ICD-10 Finland
Disseminated intravascular coagulation [defibrination syndrome]
+∞
12.5
12
*
A08
ICPC
Swelling
2.0
12.5
160
817
9940/3-C42.1
ICD-O-3
Hairy cell leukemia, NOS, of bone marrow
24.3
12.4
17
7
120
Kela drug reimbursment
Hypogammaglobulinaemia
9.3
12.4
25
27
9983/3-C42.1
ICD-O-3
Myelodysplastic syndrome with excess blasts of bone marrow
130.3
12.4
13
*
D07AA02
ATC
hydrocortisone; topical
1.4
12.4
539
3863
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.8
12.4
202
1126
M31.1
ICD-10 Finland
Thrombotic microangiopathy
13.2
12.4
21
16
ZZA00
NOMESCO Finland
Split skin graft
2.2
12.3
120
546
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
4.8
12.3
40
84
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
3.9
12.3
49
126
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
12.3
612
4506
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.3
12.2
840
6525
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.8
12.2
194
1072
K78
ICPC
Atrial fibrillation/flutter
1.6
12.2
288
1796
N30.0
ICD-10 Finland
Acute cystitis
1.5
12.1
508
3615
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
12.1
2949
26840
SPAT1255
SPAT
Intravenous administration of medicine
1.7
12.1
261
1588
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.4
12.1
551
3990
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
3.9
12.1
49
128
K70.9
ICD-10 Finland
Alcoholic liver disease, unspecified
6.9
12.1
29
42
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
4.5
12.0
41
91
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
8.7
12.0
25
29
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
3.3
12.0
60
186
A03
ICPC
Fever
1.4
11.9
623
4625
130
Kela drug reimbursment
Malignant tumour
1.6
11.9
314
2017
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.5
11.9
448
3121
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
11.9
1090
8834
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
2.3
11.8
106
466
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
2.6
11.8
86
339
Z01.7
ICD-10 Finland
Laboratory examination
1.5
11.7
422
2912
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.0
11.6
149
761
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
11.5
1544
13114
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
11.5
621
4631
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
4.6
11.5
39
86
C01DA14
ATC
isosorbide mononitrate; oral
1.4
11.5
592
4383
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
8.6
11.5
24
28
28798
ICD-8 Finland
Purpura and other haemorrhagic conditions, Purpura et status haemorrhagicus alius
+∞
11.5
11
*
M36.4
ICD-10 Finland
Arthropathy in hypersensitivity reactions classified elsewhere
+∞
11.5
11
*
2873X
ICD-9 Finland
Purpura and other haemorrhagic conditions, Primary thrombocytopenia[THROMBOCYTOPENIA PRIMARIA NUD]
+∞
11.5
11
*
QDA10
NOMESCO Finland
Incision of skin of lower limb
4.1
11.5
43
105
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.0
11.4
139
695
J01CF05
ATC
flucloxacillin; systemic
2.0
11.4
150
775
E000006
ATC
NA
1.6
11.4
272
1701
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.5
11.4
87
352
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
11.3
480
3424
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
7.8
11.3
25
32
A04
ICPC
Weakness/tiredness general
1.4
11.3
498
3580
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
2.8
11.2
70
250
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
8.9
11.2
23
26
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.6
11.2
308
1995
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.7
11.2
242
1472
J02AC01
ATC
fluconazole; systemic
1.3
11.2
1487
12607
B02.9
ICD-10 Finland
Zoster without complication
1.7
11.2
222
1320
K70.0
ICD-10 Finland
Alcoholic fatty liver
4.7
11.2
37
80
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.7
11.2
213
1252
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.6
11.2
309
2009
N06AX11
ATC
mirtazapine; oral
1.3
11.1
1196
9881
K76.6
ICD-10 Finland
Portal hypertension
25.1
11.1
15
6
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
7.6
11.1
25
33
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
6.8
11.1
27
40
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
11.1
1102
9012
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
6.4
11.1
28
44
ZXA10
NOMESCO Finland
Bilateral
1.3
11.0
718
5525
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
2.8
11.0
67
238
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
11.1
11.0
20
18
J01FA10
ATC
azithromycin; systemic
1.2
11.0
2362
21108
L01BB02
ATC
mercaptopurine; oral
3.2
11.0
55
171
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.2
11.0
115
541
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.9
11.0
157
838
JAH01
NOMESCO Finland
Laparoscopy
1.9
11.0
167
913
D45
ICD-10 Finland
Polycythaemia vera
3.6
10.9
48
135
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.0
10.9
133
667
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.3
10.9
97
426
SPAT1088
SPAT
Blood transfusion
4.6
10.9
36
78
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.2
10.8
102
459
DKW00
NOMESCO Finland
Cauterisation of mucosa of nose
3.3
10.8
52
157
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
6.9
10.8
26
38
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
6.9
10.8
26
38
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
4.8
10.8
35
74
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
15.5
10.8
17
11
C08CA05
ATC
nifedipine; systemic
1.6
10.8
248
1534
I50
ICD-10 Finland
Heart failure
2.1
10.7
118
568
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.7
10.7
214
1275
SPAT1254
SPAT
Administration of medicine
1.4
10.7
570
4242
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.4
10.6
89
378
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
3.9
10.6
42
108
SPAT1229
SPAT
Assessment of need for aid
1.6
10.6
286
1847
128
Kela drug reimbursment
Cancers of female genital organs
2.7
10.6
68
250
SPAT1301
SPAT
No procedures
1.3
10.6
1264
10567
I50.1
ICD-10 Finland
Left ventricular failure
1.8
10.6
177
1000
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.6
10.5
254
1595
K72.1
ICD-10 Finland
Chronic hepatic failure
11.2
10.5
19
17
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.8
10.5
163
896
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
3.0
10.5
57
189
E000002
ATC
NA
1.4
10.4
427
3025
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.6
10.4
267
1700
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.8
10.4
187
1079
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
5.0
10.4
32
64
205
Kela drug reimbursment
Chronic hypertension
1.3
10.4
1071
8790
N17.8
ICD-10 Finland
Other acute renal failure
3.2
10.4
53
168
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
10.4
1253
10490
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.5
10.4
378
2616
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
6.8
10.3
25
37
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.3
10.3
95
422
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.4
10.3
513
3773
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
6.4
10.3
26
41
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
6.4
10.3
26
41
M81.4
ICD-10 Finland
Drug-induced osteoporosis
6.4
10.3
26
41
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.5
10.3
80
328
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.1
10.2
110
525
UJF92
NOMESCO Finland
Capsular endoscopy
2.3
10.2
92
405
XF404
NOMESCO Finland
Ambulatory ECG
1.5
10.2
349
2382
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
3.8
10.1
41
108
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
2.9
10.1
60
210
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
2.3
10.1
89
389
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.7
10.1
215
1307
J45.9
ICD-10 Finland
Asthma, unspecified
1.3
10.1
650
4991
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.6
10.0
68
259
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
10.0
10.0
19
19
J47
ICD-10 Finland
Bronchiectasis
2.5
10.0
78
320
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
5.1
10.0
30
59
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
40.1
10.0
12
*
C07AB02
ATC
metoprolol; systemic
1.3
10.0
788
6237
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
1.8
10.0
177
1019
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
16.7
9.9
15
9
D75.2
ICD-10 Finland
Essential thrombocytosis
3.6
9.8
42
116
SPAT1211
SPAT
Application of soft bandage
1.5
9.8
340
2324
JAH00
NOMESCO Finland
Laparotomy
2.1
9.8
107
516
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
20.0
9.8
14
7
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
9.8
1656
14379
EB1WA
NOMESCO Finland
NA
3.9
9.8
38
97
SPAT1151
SPAT
Treatment of major wounds
3.0
9.8
53
176
M05BA07
ATC
risedronic acid; oral
2.0
9.8
114
566
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.7
9.8
218
1341
SAA03
NOMESCO Finland
Extended examination of mouth
1.2
9.7
1540
13274
137
Kela drug reimbursment
Uraemia requiring dialysis
3.2
9.7
48
149
SPAT1234
SPAT
Support of social functional capacity
1.7
9.7
178
1033
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
3.3
9.7
46
139
TK810
NOMESCO Finland
Hemofiltration
4.2
9.6
35
84
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.3
9.6
797
6352
I35.2
ICD-10 Finland
Aortic (valve) stenosis with insufficiency
2.1
9.6
100
472
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.6
9.6
226
1413
A04AD12
ATC
aprepitant; systemic
2.4
9.5
78
327
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.6
9.5
262
1701
H04.10
ICD-10 Finland
Dry eye syndrome
1.5
9.5
342
2357
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
1.8
9.5
147
809
TFP20
NOMESCO Finland
Cardiodefibrillation
1.6
9.5
265
1728
AAA10
NOMESCO Finland
Biopsy through craniotomy
15.0
9.5
15
10
N05CD07
ATC
temazepam; oral
1.4
9.5
447
3255
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.5
9.5
360
2514
306
Kela drug reimbursment
Erythropoietin and darbepoetin
5.7
9.5
26
46
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
3.1
9.5
50
163
T81.9
ICD-10 Finland
Unspecified complication of procedure
2.5
9.4
71
285
B81
ICPC
Anaemia vit B12/folate deficiency
1.9
9.4
136
730
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
2.3
9.4
86
384
WF004
NOMESCO Finland
Palliative radiotherapy
2.4
9.3
77
325
103
Kela drug reimbursment
Diabetes, insulin-treated
1.3
9.3
1000
8235
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
12.3
9.3
16
13
I10
ICD-10 Finland
Essential (primary) hypertension
1.2
9.3
2248
20199
K29.6
ICD-10 Finland
Other gastritis
2.9
9.3
54
187
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
3.8
9.3
37
97
M31.8
ICD-10 Finland
Other specified necrotizing vasculopathies
10.7
9.3
17
16
C82.1
ICD-10 Finland
Follicular lymphoma grade II
3.7
9.3
38
102
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.5
9.3
307
2083
K29.7
ICD-10 Finland
Gastritis, unspecified
1.9
9.3
129
685
K65.0
ICD-10 Finland
Acute peritonitis
3.0
9.3
53
180
R55
ICD-10 Finland
Syncope and collapse
1.4
9.2
400
2868
M10.0
ICD-10 Finland
Idiopathic gout
2.0
9.2
118
607
ZX114
NOMESCO Finland
Intramuscular
2.6
9.2
63
242
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
5.4
9.2
26
48
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
2.4
9.2
73
304
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
2.5
9.1
69
277
C09AA02
ATC
enalapril; systemic
1.3
9.1
737
5848
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
2.3
9.1
84
375
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.6
9.1
231
1472
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.5
9.1
324
2233
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
2.2
9.1
90
417
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.6
9.1
226
1433
K08.3
ICD-10 Finland
Retained dental root
1.6
9.1
248
1611
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
2.4
9.1
72
298
N05BA01
ATC
diazepam; systemic, rectal
1.4
9.1
482
3583
SPAT1260
SPAT
Consultation of another employee
1.3
9.1
665
5204
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
8.3
9.0
19
23
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
8.3
9.0
19
23
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.4
9.0
389
2783
D09AB01
ATC
zinc bandage without supplements; topical
2.3
9.0
78
338
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
15.6
9.0
14
9
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
15.6
9.0
14
9
C83.71
ICD-10 Finland
Burkitt's tumour
36.7
9.0
11
*
D73.0
ICD-10 Finland
Hyposplenism
36.7
9.0
11
*
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.6
9.0
230
1469
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.6
9.0
233
1493
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.8
9.0
146
817
TDM10
NOMESCO Finland
Puncture of maxillary antrum
1.8
8.9
144
804
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
2.8
8.9
54
193
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
1.7
8.9
192
1172
M30.8
ICD-10 Finland
Other conditions related to polyarteritis nodosa
18.6
8.9
13
7
C01AA05
ATC
digoxin; systemic
1.5
8.9
298
2028
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.5
8.9
334
2331
A04AA55
ATC
palonosetron, combinations; systemic
2.0
8.9
102
503
A10AE05
ATC
insulin detemir; parenteral
1.6
8.8
209
1308
196
Kela drug reimbursment
Paricalcitol and cinacalcet
4.8
8.8
28
59
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
4.4
8.8
30
68
R04.2
ICD-10 Finland
Haemoptysis
1.9
8.8
123
653
R03AC02
ATC
salbutamol; inhalant
1.2
8.8
2104
18850
WX730
NOMESCO Finland
Conventional respirator
2.4
8.8
68
280
S16
ICPC
Bruise/contusion
1.9
8.8
115
598
AN1
HP
Coronary angiography
1.4
8.8
430
3155
B72
ICPC
Hodgkin Lymphoma
9.5
8.8
17
18
B99
ICPC
Blood/lymph/spleen disease other
4.6
8.8
29
64
L03.9
ICD-10 Finland
Cellulitis, unspecified
2.2
8.7
84
383
N05BA06
ATC
lorazepam; systemic, sublingual
1.7
8.7
184
1116
Z01.9
ICD-10 Finland
Special examination, unspecified
1.6
8.7
196
1213
M05BX04
ATC
denosumab; parenteral
1.7
8.7
165
970
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
3.2
8.7
43
135
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
1.8
8.6
149
853
RD210
NOMESCO Finland
NA
2.2
8.6
83
378
UJD02
NOMESCO Finland
Gastroscopy
1.7
8.6
173
1034
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.9
8.6
128
698
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
2.0
8.6
105
532
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
8.6
600
4661
TGD00
NOMESCO Finland
Needle biopsy of lung
4.3
8.6
30
70
WNF00
NOMESCO Finland
Infection source and contact determination
4.3
8.6
30
70
ZX100
NOMESCO Finland
Oral
2.6
8.6
62
244
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
8.2
8.6
18
22
D51.9
ICD-10 Finland
Vitamin B12deficiency anaemia, unspecified
2.9
8.5
50
175
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
9.0
8.5
17
19
B28
ICPC
Limited function/disability (B)
4.4
8.5
29
66
J45.1
ICD-10 Finland
Nonallergic asthma
1.5
8.5
249
1643
I83.2
ICD-10 Finland
Varicose veins of lower extremities with both ulcer and inflammation
3.9
8.5
33
85
D59.5
ICD-10 Finland
Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]
27.5
8.5
11
*
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
27.5
8.5
11
*
A02BA03
ATC
famotidine; systemic
1.8
8.5
149
857
B83
ICPC
Purpura/coagulation defect
20.0
8.5
12
6
D83.9
ICD-10 Finland
Common variable immunodeficiency, unspecified
20.0
8.5
12
6
XG410
NOMESCO Finland
Flow-volume spirometry
1.7
8.4
154
894
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.2
8.4
1069
8965
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.8
8.4
136
762
D68.4
ICD-10 Finland
Acquired coagulation factor deficiency
90.2
8.4
9
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.6
8.4
214
1367
HA1AA
NOMESCO Finland
X-ray mammography
1.6
8.4
234
1527
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
2.6
8.4
58
225
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.4
8.4
415
3051
2874X
ICD-9 Finland
Purpura and other haemorrhagic conditions, Secondary thrombocytopenia[THROMBOCYTOPENIA SECUNDARIA NUD]
+∞
8.3
8
*
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
5.8
8.3
22
38
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.1
8.3
84
395
N03.3
ICD-10 Finland
Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis
9.4
8.3
16
17
A29
ICPC
General symptom/complaint other
1.4
8.2
396
2895
L52
ICD-10 Finland
Erythema nodosum
3.7
8.2
34
93
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.5
8.2
63
257
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
1.9
8.2
106
550
I82.9
ICD-10 Finland
Embolism and thrombosis of unspecified vein
2.5
8.2
63
258
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.4
8.2
333
2359
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
3.4
8.2
37
109
RS220
NOMESCO Finland
NA
2.5
8.1
60
241
ZX080
NOMESCO Finland
Image guided radiotherapy
2.2
8.1
78
358
L01AX03
ATC
temozolomide; systemic
3.7
8.1
33
89
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
1.7
8.1
177
1087
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
3.0
8.1
44
148
A07EA06
ATC
budesonide; oral, local oral
1.8
8.1
123
674
SXC03
NOMESCO Finland
Other oral or dental procedure
2.9
8.1
47
164
WW402
NOMESCO Finland
Leucoferesis
8.1
8.1
17
21
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
11.7
8.1
14
12
390
Kela drug reimbursment
Ibrutinib
11.7
8.1
14
12
81
HP
Angiography of the heart and coronary arteries
1.5
8.1
235
1552
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
2.2
8.0
80
373
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.4
8.0
393
2880
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.6
8.0
196
1239
D02AX
ATC
Other emollients and protectives
1.8
8.0
127
708
9680/3-C71.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of brain, NOS
22.0
8.0
11
5
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.0
8.0
104
538
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
4.3
8.0
28
66
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.5
8.0
252
1694
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
1.9
8.0
104
540
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
4.6
8.0
26
57
L04AX04
ATC
lenalidomide; oral
4.6
8.0
26
57
K59.1
ICD-10 Finland
Functional diarrhoea
1.6
8.0
177
1090
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
3.2
8.0
39
122
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
1.8
7.9
120
659
153
Kela drug reimbursment
Lenalidomid
4.4
7.9
27
62
B82
ICPC
Anaemia other/unspecified
2.0
7.8
90
445
K74.3
ICD-10 Finland
Primary biliary cirrhosis
4.0
7.8
29
72
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.4
7.8
408
3027
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
2.8
7.8
46
163
I48.2
ICD-10 Finland
Chronic atrial fibrillation
2.0
7.8
88
435
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
9.4
7.8
15
16
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.3
7.7
67
293
B01AX05
ATC
fondaparinux; parenteral
3.1
7.7
39
125
WX400
NOMESCO Finland
Inhalation anesthesy
1.7
7.7
153
916
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
3.3
7.7
36
109
A02BA02
ATC
ranitidine; systemic
1.3
7.7
705
5681
XCK10
NOMESCO Finland
Photography of fundus of eye
1.4
7.7
365
2661
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.5
7.7
226
1496
N03AX12
ATC
gabapentin; oral
1.3
7.6
529
4102
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
1.9
7.6
108
580
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
2.7
7.6
50
189
G40.9
ICD-10 Finland
Epilepsy, unspecified
1.8
7.6
123
691
207
Kela drug reimbursment
Chronic arrhythmias
1.3
7.6
503
3874
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.6
7.6
180
1132
H03AA01
ATC
levothyroxine sodium; systemic
1.3
7.6
813
6680
C95.9
ICD-10 Finland
Leukaemia, unspecified
11.8
7.6
13
11
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
2.1
7.6
84
412
M31.3
ICD-10 Finland
Wegener granulomatosis
4.9
7.6
23
47
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
1.6
7.6
194
1243
D53.1
ICD-10 Finland
Other megaloblastic anaemias, not elsewhere classified
6.1
7.5
19
31
R05
ICD-10 Finland
Cough
1.3
7.5
703
5679
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.6
7.5
192
1231
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.2
7.5
865
7167
T90
ICPC
Diabetes non-insulin dependent
1.3
7.5
802
6589
XX9XE
NOMESCO Finland
Other ultrasound examination
3.0
7.5
40
134
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.2
7.4
75
350
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
4.8
7.4
23
48
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
3.6
7.4
31
86
Z49.2
ICD-10 Finland
Other dialysis
3.3
7.4
35
107
D76.1
ICD-10 Finland
Haemophagocytic lymphohistiocytosis
80.2
7.4
8
*
EBA10
NOMESCO Finland
Surgical removal of tooth
1.4
7.4
428
3229
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
2.2
7.4
67
300
V03AE03
ATC
lanthanum carbonate; oral
5.3
7.4
21
40
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
4.5
7.4
24
53
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
2.7
7.4
48
181
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
1.8
7.3
111
609
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.4
7.3
368
2709
AA1
HP
Conventional CABG
2.1
7.3
77
368
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
1.8
7.3
113
625
D61.8
ICD-10 Finland
Other specified aplastic anaemias
+∞
7.3
7
*
2878X
ICD-9 Finland
Purpura and other haemorrhagic conditions, Other specified haemorrhagic conditions
+∞
7.3
7
*
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
2.5
7.3
52
207
K29
ICPC
Cardiovascular sympt/complt other
1.7
7.3
147
885
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
9.4
7.3
14
15
PG1CG
NOMESCO Finland
Extensive MRI examination of vasculature with high intensity magnet not elsewhere classified
9.4
7.3
14
15
1CX01
NOMESCO Finland
NA
9.4
7.3
14
15
L01AA02
ATC
chlorambucil; oral
4.9
7.3
22
45
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.2
7.3
35
109
I27.0
ICD-10 Finland
Primary pulmonary hypertension
6.2
7.2
18
29
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
3.1
7.2
36
115
R4120
NOMESCO Finland
Occupational therapy
1.5
7.2
213
1415
ZY010
NOMESCO Finland
Hospital outpatient
1.6
7.2
177
1123
I95.1
ICD-10 Finland
Orthostatic hypotension
1.8
7.2
117
659
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.3
7.1
724
5909
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
4.4
7.1
24
55
318
Kela drug reimbursment
Teriparatide
4.4
7.1
24
55
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.0
7.1
89
457
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
3.3
7.1
33
100
B05DA
ATC
Isotonic solutions
3.2
7.1
35
111
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
6.6
7.1
17
26
L04AA05
ATC
[U] tacrolimus; systemic
7.9
7.1
15
19
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
2.8
7.1
42
150
E86
ICD-10 Finland
Volume depletion
2.0
7.1
84
421
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
7.1
89
460
DKW30
NOMESCO Finland
Cauterisation of artery of internal nose
3.5
7.0
30
85
M32
ICD-10 Finland
Systemic lupus erythematosus
8.8
7.0
14
16
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
1.5
7.0
226
1526
N05BB01
ATC
hydroxyzine; systemic
1.5
7.0
214
1428
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
2.0
7.0
86
439
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
1.8
7.0
110
612
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.0
7.0
79
389
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.6
7.0
167
1053
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
2.8
6.9
41
146
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
2.6
6.9
47
183
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.6
6.9
187
1214
R06
ICPC
Nose bleed/epistaxis
2.0
6.9
85
432
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
4.2
6.9
24
57
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
2.3
6.9
59
259
M31.0
ICD-10 Finland
Hypersensitivity angiitis
13.8
6.9
11
8
K50.1
ICD-10 Finland
Crohn disease of large intestine
2.5
6.9
49
195
NK4AT
NOMESCO Finland
Puncture of joint with ultrasound guidance not elsewher classified
3.2
6.9
33
103
A10BH05
ATC
linagliptin; oral
1.6
6.8
151
931
D07AD01
ATC
clobetasol; topical
1.3
6.8
540
4267
N06AA09
ATC
amitriptyline; systemic
1.4
6.8
334
2448
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.3
6.8
470
3641
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
8.3
6.8
14
17
E000003
ATC
NA
1.6
6.8
162
1020
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
2.6
6.8
46
179
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.5
6.8
216
1459
PG1XE
NOMESCO Finland
Other ultrasound examination of blood vessel not elsewhere classified
4.2
6.8
24
58
ZYC01
NOMESCO Finland
Remote contact by phone
1.6
6.8
160
1003
SPAT1172
SPAT
Guidance concerning hydration
2.1
6.8
75
366
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.7
6.8
135
810
E66.00
ICD-10 Finland
Metabolic syndrome
1.6
6.8
168
1070
D02AE01
ATC
carbamide; topical
1.5
6.7
227
1549
PC1BC
NOMESCO Finland
Extensive angiography of aorta and abdominal arteries
5.6
6.7
18
32
H05BX01
ATC
cinacalcet; oral
3.7
6.7
27
73
D59.3
ICD-10 Finland
Haemolytic-uraemic syndrome
16.7
6.7
10
6
W19
ICD-10 Finland
Unspecified fall
1.4
6.7
334
2457
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.7
6.7
143
873
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
1.8
6.7
115
658
PAW37
NOMESCO Finland
Biopsy of temporal artery
3.2
6.7
33
105
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
1.8
6.7
115
661
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
1.8
6.7
98
535
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
2.1
6.7
70
336
9811/3-C42.1
ICD-O-3
B lymphoblastic leukemia/lymphoma, NOS, of bone marrow
22.5
6.7
9
*
J01CA08
ATC
pivmecillinam; oral
1.2
6.7
1409
12399
L84
ICD-10 Finland
Corns and callosities
1.8
6.7
109
615
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.0
6.6
79
400
ZXC40
NOMESCO Finland
Use of ultrasound
3.1
6.6
33
106
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
5.1
6.6
19
37
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
5.1
6.6
19
37
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
2.7
6.6
41
152
K74.0
ICD-10 Finland
Hepatic fibrosis
7.8
6.6
14
18
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
7.8
6.6
14
18
Y96.9
ICD-10 Finland
Unspecified type of accident
2.1
6.6
65
305
N29
ICPC
Neurological sympt/complt other
2.2
6.6
64
296
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.2
6.6
740
6112
F10.20
ICD-10 Finland
Alcohol dependence currently independent
2.1
6.6
72
353
D70
ICD-10 Finland
Agranulocytosis
12.2
6.6
11
9
C92.4
ICD-10 Finland
Acute promyelocytic leukaemia [PML]
12.2
6.6
11
9
SPAT1231
SPAT
Assessment of adjustments needed in living environment
2.1
6.6
69
331
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
3.6
6.6
27
75
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
2.2
6.5
59
265
R80
ICD-10 Finland
Isolated proteinuria
2.9
6.5
36
124
L01BB05
ATC
fludarabine; systemic
8.7
6.5
13
15
Z49.0
ICD-10 Finland
Preparatory care for dialysis
2.6
6.5
44
171
SPAT1245
SPAT
Provision of support and information to patient’s family members
1.7
6.5
138
843
D46.1
ICD-10 Finland
Refractory anaemia with ring sideroblasts
10.0
6.5
12
12
T80.8
ICD-10 Finland
Other complications following infusion, transfusion and therapeutic injection
10.0
6.5
12
12
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
2.6
6.5
46
181
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
4.3
6.5
22
51
NF1AA
NOMESCO Finland
Hip X-ray examination
1.4
6.5
282
2025
WX199
NOMESCO Finland
Other local analgesia
1.9
6.5
91
490
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.6
6.5
173
1121
AB2
HP
AVR bio, stent
3.0
6.5
35
119
SPAT1312
SPAT
General health counselling
1.2
6.5
1242
10830
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
2.2
6.5
61
279
R05FB02
ATC
cough suppressants and expectorants
1.2
6.5
1402
12360
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.4
6.5
279
2004
QDB99
NOMESCO Finland
Other procedure for wound of skin of lower limb
3.5
6.5
28
81
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
2.5
6.5
46
183
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.4
6.5
273
1952
9101
FHL
Bone biopsy
6.2
6.5
16
26
J96.0
ICD-10 Finland
Acute respiratory failure
2.5
6.4
47
191
E66.8
ICD-10 Finland
Other obesity
1.6
6.4
163
1044
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
2.7
6.4
42
159
J05AX18
ATC
letermovir; oral
69.9
6.4
7
*
D01AC03
ATC
econazole; topical
1.5
6.4
204
1377
WZA10
NOMESCO Finland
Long statement of health and health related matters
2.4
6.4
52
221
R33
ICD-10 Finland
Retention of urine
1.4
6.4
271
1937
K02.1
ICD-10 Finland
Caries of dentine
1.2
6.4
2270
20834
L01XE27
ATC
[U] ibrutinib; oral
14.3
6.4
10
7
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.1
6.4
70
342
R05
ICPC
Cough
1.2
6.4
794
6630
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.2
6.4
848
7129
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
4.0
6.4
23
57
R07.3
ICD-10 Finland
Other chest pain
1.4
6.3
320
2361
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.3
6.3
379
2877
V03AE04
ATC
calcium acetate and magnesium carbonate; systemic
8.1
6.3
13
16
C07AA05
ATC
propranolol; systemic
1.3
6.3
673
5522
H05AA02
ATC
teriparatide; parenteral
4.2
6.3
22
53
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
4.2
6.3
22
53
QX4YT
NOMESCO Finland
Puncture of superficial collection under ultrasound guidance
5.9
6.3
16
27
WW400
NOMESCO Finland
Plasmaferesis
5.9
6.3
16
27
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
2.7
6.3
41
155
K65.8
ICD-10 Finland
Other peritonitis
5.5
6.3
17
31
L50.9
ICD-10 Finland
Urticaria, unspecified
1.7
6.3
120
712
GD2SN
NOMESCO Finland
Lung ventilation SPECT
3.5
6.3
27
78
1BC01
NOMESCO Finland
NA
+∞
6.2
6
*
D59.0
ICD-10 Finland
Drug-induced autoimmune haemolytic anaemia
+∞
6.2
6
*
2870X
ICD-9 Finland
Purpura and other haemorrhagic conditions, Allergic purpura[PURPURA ALLERGICA NUD]
+∞
6.2
6
*
2864A
ICD-9 Finland
Coagulation defects, von Willebrand's disease
+∞
6.2
6
*
2873C
ICD-9 Finland
Purpura and other haemorrhagic conditions, Primary thrombocytopenia[THROMBOCYTOPENIA PRIMARIA ALIA DEFINITA]
+∞
6.2
6
*
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.4
6.2
336
2505
D89.1
ICD-10 Finland
Cryoglobulinaemia
26.7
6.2
8
*
N08.2*D59.3
ICD-10 Finland
Glomerular disorders in haemolytic-uraemic syndrome
26.7
6.2
8
*
M79.6
ICD-10 Finland
Pain in limb
1.2
6.2
1320
11612
L40.0
ICD-10 Finland
Psoriasis vulgaris
1.6
6.2
143
896
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
1.7
6.2
116
687
FPE00
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with ventricular electrode
2.0
6.2
69
342
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
3.9
6.2
23
59
WYA20
NOMESCO Finland
Home visit
2.2
6.2
57
261
M10
ICD-10 Finland
Gout
1.6
6.1
144
905
K76.7
ICD-10 Finland
Hepatorenal syndrome
5.7
6.1
16
28
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
1.7
6.1
115
678
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
6.1
91
498
E66.01
ICD-10 Finland
Obesity due to excess calories
1.4
6.1
246
1742
N01BB20
ATC
amides - combinations; parenteral
2.9
6.1
33
113
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
2.0
6.1
68
336
C81.2
ICD-10 Finland
Mixed cellularity classical Hodgkin lymphoma
12.5
6.1
10
8
D70.81
ICD-10 Finland
Neutropenia congenital
12.5
6.1
10
8
S00.0
ICD-10 Finland
Superficial injury of scalp
2.0
6.1
75
387
5BA08
NOMESCO Finland
NA
3.6
6.1
25
70
WVA20
NOMESCO Finland
Medicine administration
1.9
6.0
77
402
R10.0
ICD-10 Finland
Acute abdomen
1.7
6.0
104
601
FMD10
NOMESCO Finland
Replacement of aortic valve using biological prosthesis
2.2
6.0
58
269
1512
Kela drug reimbursment
Ibrutinib
10.0
6.0
11
11
D60.9
ICD-10 Finland
Acquired pure red cell aplasia, unspecified
10.0
6.0
11
11
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.2
6.0
808
6798
201
Kela drug reimbursment
Chronic cardiac insufficiency
1.5
6.0
174
1153
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002030) Lymphocytes/100 leukocytes in Blood
3651
21784
2.98
319.29
12.1
6.1
%
27.4
28.0
2.46
3519
20262
(3013115) Eosinophils [#/volume] in Blood
3802
23206
3.04
318.42
12.0
6.0
e9/l
0.2
0.2
26.13
3498
20299
(3019198) Lymphocytes [#/volume] in Blood
3777
23045
3.01
315.07
11.5
5.9
e9/l
1.8
1.9
4.97
3493
20220
(21494434) Karyotype in Bone marrow
403
345
12.52
307.65
1.3
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
503
457
12.01
307.65
1.6
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
657
1002
7.30
307.65
2.3
1.6
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
739
1279
6.51
307.65
3.4
3.1
g/l
3.3
3.5
3.25
708
1210
(3023520) Reticulocytes [#/volume] in Blood
1459
3713
4.98
307.65
4.8
2.5
e9/l
77.4
68.6
6.49
1130
2780
(3042111) Morphology [Interpretation] in Bone marrow Narrative
785
675
13.39
307.65
1.9
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
1820
5025
4.91
307.65
4.7
2.6
%
1.9
1.7
7.69
1691
4430
(3019069) Monocytes/100 leukocytes in Blood
3613
21170
3.03
307.65
12.4
6.3
%
9.3
8.6
17.86
3481
19791
(42870588) Differential panel, method unspecified - Blood
2986
15294
3.07
307.65
11.2
5.9
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
3591
21037
3.01
307.65
12.0
6.0
%
2.5
2.9
16.02
3463
19570
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1733
6845
3.23
307.65
3.5
2.2
s
30.4
29.9
2.28
1684
6633
(3001604) Monocytes [#/volume] in Blood
3731
22364
3.05
307.65
11.3
5.8
e9/l
0.6
0.6
0.16
3418
19233
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1866
4987
5.13
307.65
7.2
4.1
u/l
268.0
241.6
4.73
1802
4709
(3022096) Basophils/100 leukocytes in Blood
3532
20428
3.01
307.65
11.9
6.1
%
0.6
0.7
2.19
3407
19031
(3028026) IgM [Mass/volume] in Serum or Plasma
1071
2602
4.86
307.65
2.2
1.9
g/l
1.2
1.4
1.95
990
2373
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
873
2004
4.98
307.65
2.4
1.7
g/l
1.3
1.5
10.20
736
1726
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
580
866
7.36
307.65
7.0
5.8
iu/ml
3023.0
595.8
0.49
90
122
(3006315) Basophils [#/volume] in Blood
3743
22450
3.06
307.65
11.3
5.8
e9/l
0.0
0.0
9.43
3421
19320
(3005719) IgG [Mass/volume] in Serum or Plasma
1271
3322
4.67
307.65
4.0
2.7
g/l
10.2
10.5
1.16
1186
3036
(3000093) Morphology [Interpretation] in Blood Narrative
435
386
12.14
307.65
1.2
1.1
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
3570
21450
2.87
300.51
11.3
5.9
%
57.0
57.2
0.24
3433
20034
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
456
677
7.25
295.28
3.4
3.5
u/ml
15728.9
1528.1
0.50
38
43
(3017143) Hepatitis C virus Ab [Presence] in Serum
1402
5234
3.25
284.78
1.8
1.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1698
7111
3.00
282.02
6.5
3.5
mmol/l
0.8
0.8
8.15
1620
6625
(3013650) Neutrophils [#/volume] in Blood by Automated count
3966
25878
2.88
272.37
20.3
8.7
e9/l
3.8
4.1
11.14
3658
22494
(3021879) Hepatitis B virus core Ab [Presence] in Serum
1033
3330
3.58
263.91
1.5
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
1099
3719
3.44
259.98
6.6
4.1
%
1.2
0.9
2.68
611
1015
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
569
1194
5.20
257.40
4.0
2.7
%
183.2
190.8
1.07
549
1136
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
602
1342
4.91
253.54
3.3
3.0
%
91.0
90.8
0.08
584
1266
(3004588) Protein electrophoresis panel - Serum or Plasma
934
2915
3.65
249.80
2.5
2.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
334
428
8.24
245.41
3.1
2.6
e9/l
1.0
1.1
1.24
234
255
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1440
5904
2.94
243.99
9.3
6.1
mmol/l
1.1
1.1
1.84
1367
5510
(3020630) Protein [Mass/volume] in Serum or Plasma
1051
3595
3.37
243.18
2.9
2.6
g/l
65.6
66.3
1.68
983
3280
(3023368) Bacteria identified in Blood by Culture
2319
12125
2.57
242.65
7.6
4.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1456
6051
2.91
240.18
3.4
2.6
%
24.1
22.7
2.32
1339
5175
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
288
319
9.47
237.59
2.6
2.3
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
303
364
8.75
234.60
2.9
2.5
%
33.0
43.3
2.23
31
47
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
288
333
9.07
229.80
2.6
2.3
%
13.8
12.5
0.52
110
169
(1175426) CD3 cells/100 lymphocytes in Blood
290
340
8.95
228.88
2.7
2.3
%
73.9
72.1
0.82
279
326
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1501
6504
2.79
227.27
3.4
2.5
g/l
2.3
2.3
5.73
1431
6012
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
3516
22771
2.49
224.44
12.6
6.0
umol/l
13.2
11.8
4.50
3398
21554
(3022948) Iron [Moles/volume] in Serum or Plasma
1573
7034
2.73
223.50
3.4
2.5
umol/l
13.0
13.1
0.12
1505
6518
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
548
1263
4.71
220.79
2.5
1.6
g/l
0.2
0.2
4.66
505
1196
(3021440) Promyelocytes/100 leukocytes in Blood
1007
3550
3.24
220.18
6.7
4.1
%
0.2
0.1
3.62
560
945
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1553
6974
2.70
218.08
1.8
1.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
1371
5828
2.80
213.80
1.6
1.3
titre
679.2
530.8
1.51
334
1190
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
551
1308
4.57
213.78
2.5
1.6
g/l
1.1
1.2
2.27
515
1236
(3024561) Albumin [Mass/volume] in Serum or Plasma
3066
18991
2.38
211.53
8.6
4.8
g/l
34.1
35.5
33.02
2911
17623
(3009445) Proteinase 3 Ab [Units/volume] in Serum
660
1824
3.97
208.99
1.6
1.6
u/ml
12.0
16.8
0.46
23
53
(3002179) Metamyelocytes/100 leukocytes in Blood
962
3404
3.21
208.23
6.4
3.9
%
0.9
0.6
2.23
446
738
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
194
152
13.19
202.13
2.6
1.3
%
143.3
159.3
1.00
186
139
(3036489) Thrombin time
604
1623
4.05
198.54
3.3
2.4
s
21.8
21.5
0.81
555
1428
(3004809) Band form neutrophils/100 leukocytes in Blood
381
702
5.75
198.07
5.4
3.3
%
1.4
1.5
0.20
318
529
(3033658) Prothrombin time (PT) actual/Normal
2064
11239
2.33
185.91
7.1
4.0
%
85.4
89.2
8.03
2013
10957
(3018418) pH of Serum or Plasma
2273
12899
2.29
185.56
8.1
3.9
ph
7.4
7.4
1.23
575
2450
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
422
924
4.86
180.18
1.5
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
906
3351
3.04
179.96
6.9
4.1
%
0.3
0.3
0.01
466
797
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
3079
19956
2.22
179.30
11.1
6.1
mmol/l
1.2
1.2
4.20
2888
18093
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
3305
22039
2.24
179.26
12.5
6.8
mmol/l
1.2
1.2
4.11
2726
18651
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
457
1078
4.53
177.96
2.3
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
452
1061
4.55
177.08
2.4
1.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
1026
4097
2.85
177.02
10.9
7.7
mmol/l
10.7
9.8
2.89
976
3904
(46235355) HIV 1 and 2 tests - Meaningful Use set
1656
8429
2.38
171.91
2.0
1.9
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
378
789
5.07
170.63
2.4
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
1695
8808
2.33
166.93
2.0
1.5
g/l
2.6
2.4
3.16
1247
5318
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
387
840
4.88
166.76
1.6
1.5
u/ml
112.2
113.7
0.06
72
158
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
522
1445
3.88
163.63
1.7
1.6
titre
322.8
325.8
0.01
23
65
(21494814) CD8 cells/100 lymphocytes in Specimen
173
162
10.99
160.66
2.6
2.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
408
957
4.52
159.68
1.3
1.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
155
126
12.63
157.74
2.4
2.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
449
1159
4.13
154.91
1.6
1.4
iu/ml
14.1
12.8
0.08
16
27
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1454
7294
2.35
153.47
2.5
1.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
828
3174
2.89
152.60
2.4
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
314
621
5.30
150.53
1.8
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1783
9809
2.21
150.15
9.3
4.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
2739
17773
2.07
148.96
14.0
9.1
inr
1.3
1.3
0.15
928
5116
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
976
4139
2.65
147.65
3.3
2.3
g/l
0.2
0.2
12.42
912
3855
(3026493) Urate [Moles/volume] in Serum or Plasma
1992
11509
2.14
147.50
4.6
2.7
umol/l
2998.2
5131.3
1.77
1811
9964
(3021589) Normoblasts [#/volume] in Blood
2966
19879
2.06
146.85
20.2
9.3
e9/l
0.0
0.0
1.47
2530
16196
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
187
220
8.76
146.77
2.6
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
187
220
8.76
146.77
2.6
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1995
11562
2.13
146.28
2.9
2.3
mg/l
3.3
2.9
8.27
1799
9874
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
378
907
4.40
143.45
1.3
1.3
u/ml
280.0
269.3
0.21
251
549
(3048929) Epstein Barr virus Ab [Presence] in Serum
496
1491
3.56
137.01
1.4
1.3
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
92
33
28.33
136.76
1.5
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
359
878
4.30
132.74
1.6
1.6
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
92
37
25.27
131.38
1.4
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2888
19664
1.98
131.19
4.1
2.8
ug/l
262.1
122.3
14.45
2746
18179
(3002582) Erythrocytes [#/volume] in Urine
2202
13657
2.02
130.79
4.5
3.3
e6/l
93.4
87.0
0.10
1821
10504
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
167
197
8.71
130.73
5.2
3.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
331
773
4.49
129.86
1.7
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1069
5005
2.41
129.57
2.2
1.8
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
178
233
7.86
127.88
2.0
3.1
%
93.2
96.1
0.39
171
219
(40758558) Short blood count panel - Blood
1911
11340
2.05
127.74
14.3
6.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
262
513
5.31
126.81
1.9
1.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
4292
33842
2.19
126.80
15.7
7.4
u/l
85.0
79.0
10.88
4153
31854
(4035726)
872
3767
2.56
125.50
1.7
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
2044
12492
2.01
125.25
4.4
3.2
e6/l
0.5
0.4
0.71
1662
9438
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
528
1754
3.22
124.00
2.5
1.9
ug/l
2.4
2.4
0.02
483
1537
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
283
604
4.88
123.96
1.7
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1052
4988
2.37
123.36
2.1
1.7
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
200
317
6.51
120.67
3.3
2.8
e6/l
503.8
520.6
0.12
154
269
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1049
5016
2.35
120.37
5.0
2.9
umol/l
11.7
8.5
3.19
949
4362
(3042936) Bacteria identified in Isolate by Culture
1222
6238
2.23
119.95
2.5
2.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
2223
14152
1.95
119.65
4.7
2.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
200
321
6.43
119.20
3.7
2.6
e6/l
493.7
682.3
2.12
70
130
(3026782) Osmolality of Urine
1576
8898
2.08
119.17
3.8
2.8
mosm/kgh2o
527.1
551.0
4.44
1418
7570
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
441
1342
3.48
119.13
3.5
3.3
mg/l
35.5
60.9
1.59
345
1092
(3034860) Kappa light chains.free [Mass/volume] in Serum
441
1344
3.48
118.85
3.5
3.3
mg/l
172.6
103.2
0.24
345
1090
(3018095) Leukocytes [#/volume] in Urine
2423
15958
1.92
117.08
5.4
3.8
e6/l
101.3
101.3
0.00
1904
11278
(36304419) Bacteria [Presence] in Urine
1980
12203
1.97
116.47
4.2
3.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
278
616
4.70
116.31
1.5
1.2
u/ml
5.5
3.5
0.48
125
204
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
429
1308
3.47
115.47
3.5
3.3
ratio
2.2
2.3
0.05
30
97
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
418
1256
3.52
115.07
6.4
5.3
mg/l
1.6
1.5
1.67
395
1158
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
188
296
6.54
114.14
1.5
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1661
9689
2.02
113.90
2.6
1.8
mg/l
1.9
1.2
5.61
1336
7369
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
492
1660
3.16
112.24
2.4
2.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
492
1661
3.15
112.12
2.4
2.3
g/l
6.9
7.4
6.73
369
1247
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
491
1659
3.15
111.73
2.4
2.3
g/l
3.7
3.8
0.59
357
1194
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
189
306
6.36
111.65
3.5
2.8
e9/l
0.2
0.2
0.15
154
267
(3023183) Ammonium ion [Moles/volume] in Plasma
345
950
3.81
108.05
5.1
2.8
umol/l
38.6
34.6
1.49
303
804
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
119
116
10.46
107.35
1.3
1.1
%
107.3
102.9
0.38
112
102
(3013826) Glucose [Moles/volume] in Serum or Plasma
3484
26228
1.89
107.12
8.3
4.7
mmol/l
6.7
6.7
0.50
3343
24460
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
438
1419
3.27
106.80
2.4
2.4
g/l
0.8
1.0
0.35
370
1228
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
189
320
6.08
106.74
1.6
1.7
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
459
1553
3.13
104.01
2.5
2.3
g/l
3.1
3.1
0.01
361
1220
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
279
677
4.29
103.93
1.8
1.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
474
1635
3.08
103.90
1.4
1.2
u/ml
1.9
1.0
0.37
31
153
(3000850) Epithelial cells [#/volume] in Urine
1607
9522
1.97
103.62
3.6
2.6
e6/l
5.6
5.6
0.03
1470
8343
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
258
593
4.51
103.04
1.8
1.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
454
1546
3.11
101.69
2.3
2.4
g/l
10.7
10.2
1.25
392
1310
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
392
1245
3.31
98.56
2.4
2.3
g/l
0.0
0.0
0.17
354
1147
(3008757) Leukocyte morphology finding [Identifier] in Blood
226
484
4.83
98.43
6.5
3.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
1425
8231
1.98
98.06
2.0
1.8
nmol/l
1233.9
1162.2
1.82
1148
6186
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
255
604
4.38
97.97
1.5
1.2
u/ml
5.3
3.8
1.15
141
257
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
440
1504
3.09
97.83
4.2
3.7
u/ml
0.3
0.3
2.16
266
846
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
111
113
10.00
97.07
1.3
1.1
%
87.7
86.0
0.12
54
54
(3024471) HLA-A [Type]
120
136
9.00
96.86
1.0
1.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
1675
10267
1.91
96.32
1.8
1.5
nmol/l
18.9
20.2
3.22
1517
8789
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2881
20868
1.79
95.81
7.5
4.0
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
178
318
5.75
95.05
1.9
1.8
mg/l
4.5
4.6
0.04
168
306
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
185
345
5.51
94.35
1.9
1.5
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
369
1160
3.34
94.26
2.4
2.3
g/l
0.0
0.0
0.36
331
1067
(3016650) Hepatitis A virus Ab [Presence] in Serum
274
709
4.01
93.53
1.1
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
110
117
9.57
93.16
2.4
1.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
276
723
3.97
92.61
1.1
1.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
109
116
9.57
92.27
1.2
1.1
%
86.9
85.3
0.14
51
55
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
361
1143
3.31
91.10
2.4
2.3
g/l
0.0
0.0
0.00
331
1065
(40760888) Immunoglobulin light chains.free panel - Serum
336
1017
3.45
91.09
3.5
3.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
855
4180
2.24
90.96
2.3
2.2
nmol/l
358.5
371.4
0.87
808
3821
(21491868) Cryoglobulin [Mass/volume] in Serum
122
153
8.13
90.78
1.5
1.2
g/l
1.1
0.3
0.72
12
11
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
163
281
5.95
90.33
1.9
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
2070
13800
1.80
89.36
3.3
2.5
u/l
55.5
58.3
1.69
1922
12743
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
400
1378
3.05
87.52
1.3
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
150
246
6.24
87.43
2.0
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
384
1296
3.11
87.05
2.4
2.2
g/l
37.4
37.6
0.14
338
1118
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2125
14372
1.78
86.65
5.2
3.2
u/l
37.9
35.6
0.65
2015
13656
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
380
1281
3.11
86.30
2.0
1.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2515
17872
1.75
86.06
2.4
2.0
pmol/l
92.3
95.2
2.51
1549
9392
(3037467) Urinalysis macro (dipstick) panel - Urine
3843
30793
1.81
86.03
6.2
4.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
149
247
6.17
85.92
2.0
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
4031
32777
1.84
85.86
6.2
4.0
mm/h
15.7
12.0
31.36
3831
30311
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
383
1309
3.07
84.92
1.7
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
362
1201
3.16
84.45
1.3
1.2
titre
86.6
85.3
0.03
35
97
(3015377) Calcium [Moles/volume] in Serum or Plasma
2152
14749
1.75
82.78
4.8
3.3
mmol/l
2.3
2.4
8.01
1933
12854
(3023420) DNA double strand Ab [Units/volume] in Serum
197
438
4.63
81.91
1.8
1.4
iu/ml
33.5
23.2
0.59
18
22
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
84
73
11.67
81.79
1.2
1.2
%
73.0
76.3
0.15
22
19
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
305
929
3.42
81.76
1.6
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
208
485
4.42
81.46
2.7
1.7
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
84
74
11.51
81.08
1.3
1.1
%
71.7
82.8
0.82
24
20
(3034770) Mitochondria Ab [Titer] in Serum
355
1195
3.11
80.73
1.3
1.2
titre
724.0
1075.1
—
10
37
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
211
502
4.33
80.52
2.5
2.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
3695
29532
1.75
80.37
5.9
4.5
e6/l
185.8
1682.1
3.73
68
406
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
373
1303
3.00
79.50
3.0
1.8
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
853
4384
2.12
79.15
6.9
4.2
kpa
5.7
5.8
3.23
830
4250
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
122
179
6.95
79.12
2.6
2.5
%
31.3
28.1
1.18
113
172
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1679
10825
1.79
78.98
4.3
2.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
159
306
5.32
78.29
1.3
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
848
4368
2.11
78.15
7.0
4.2
mmol/l
1.7
1.9
0.86
714
3527
(40768795) Lymph node Pathology biopsy report
181
394
4.72
77.22
1.5
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
201
476
4.34
77.15
1.3
1.2
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
106
137
7.87
76.90
2.6
2.6
e6/l
187.9
216.4
0.26
61
78
(3000991) Gas panel - Venous blood
775
3890
2.15
76.26
10.5
8.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
194
451
4.42
76.25
1.4
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
192
443
4.45
76.19
2.8
1.7
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
141
249
5.78
76.19
4.2
2.7
%
35.7
41.1
1.17
44
85
(3007853) Bacteria identified in Skin by Aerobe culture
969
5292
2.01
75.95
2.1
1.7
—
—
—
0
0
(3024932) HLA-DR beta [Type]
104
134
7.89
75.64
1.2
1.1
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
121
185
6.66
75.50
2.8
2.6
%
10.4
11.7
0.43
107
175
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
390
1440
2.84
75.07
2.8
2.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
862
4531
2.07
75.03
5.5
3.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
250
707
3.66
75.02
1.4
1.3
u/l
93.6
37.1
3.41
229
614
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
273
819
3.45
74.88
1.3
1.2
titre
82.5
270.5
—
8
19
(3026008) Bacteria identified in Urine by Culture
1958
13356
1.72
74.61
3.7
3.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
186
445
4.29
70.43
5.2
3.3
%
54.1
58.4
1.32
124
276
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
50
21
24.02
70.00
1.2
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1254
7638
1.83
69.91
3.6
2.8
e6/l
1.1
1.2
0.21
772
4359
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1194
7167
1.85
69.77
3.8
3.0
e6/l
2.6
2.4
0.21
708
3918
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1833
12462
1.70
69.56
3.9
3.1
ng/l
1945.4
1520.8
3.02
1636
10680
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
716
3611
2.13
69.18
9.0
3.7
mmol/l
1.2
1.2
2.40
666
3151
(4268621)
177
415
4.37
68.80
2.8
2.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
2849
21737
1.64
68.77
5.1
3.6
estimate
0.0
0.0
1.34
716
4069
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
616
2938
2.23
68.47
8.6
8.0
mmol/l
24.2
24.9
4.46
609
2917
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
569
2626
2.30
68.44
1.8
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
2869
22007
1.63
67.13
5.1
3.7
estimate
0.0
0.0
0.38
713
4038
(3021601) Nitrite [Presence] in Urine by Test strip
2843
21759
1.63
67.12
6.7
4.9
estimate
0.0
0.0
0.50
737
4151
(40758292) HTLV I+II Ab panel - Serum
70
64
11.06
65.90
1.4
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
95
130
7.42
65.60
1.1
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
158
354
4.56
65.05
1.3
1.3
titre
214.1
194.9
0.10
32
71
(3010375) cycloSPORINE [Mass/volume] in Blood
119
212
5.71
63.71
31.3
26.8
ug/l
126.4
116.4
0.70
102
176
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
204
565
3.71
63.08
6.7
6.8
mg/l
11.5
11.7
0.21
194
527
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
518
2390
2.29
62.12
7.6
4.6
mmol/l
24.1
24.1
0.04
481
2178
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
654
3317
2.10
61.88
5.6
4.1
ng/l
108.4
89.8
3.44
587
2861
(44790048)
193
528
3.75
60.76
1.7
1.5
—
—
—
0
0
(44790047)
193
528
3.75
60.76
1.7
1.5
—
—
—
0
0
(44806118)
193
528
3.75
60.76
1.7
1.5
—
—
—
0
0
(44790049)
193
528
3.75
60.76
1.7
1.5
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
307
1117
2.85
60.54
2.0
1.9
mg/l
11.1
11.2
0.09
285
1030
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2420
18128
1.59
60.00
2.8
2.3
nmol/l
75.5
76.7
1.26
2230
16314
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
223
679
3.38
59.68
1.4
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
158
379
4.26
59.62
3.0
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
158
379
4.26
59.62
3.0
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
158
379
4.26
59.62
3.0
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
426
1837
2.43
59.56
1.3
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
273
940
3.00
59.48
1.2
1.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
949
5570
1.85
58.47
9.6
6.8
mmol/l
104.3
104.5
0.56
925
5449
(3024354) Oxygen [Partial pressure] in Venous blood
692
3660
2.02
58.22
6.0
3.6
kpa
4.8
4.6
1.22
669
3538
(3022217) INR in Platelet poor plasma by Coagulation assay
975
5808
1.82
57.13
26.3
25.6
inr
1.5
1.4
1.64
102
833
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
85
121
7.12
56.67
1.3
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
228
727
3.23
56.62
1.9
1.6
g/l
0.7
0.8
0.21
179
562
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
111
214
5.27
54.56
1.4
1.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
721
3956
1.95
54.36
8.8
7.0
mmol/l
1.5
1.4
1.94
700
3796
(1616796) Gas panel - Central venous blood
276
1007
2.83
54.09
4.3
3.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1225
7922
1.70
53.48
3.9
3.0
mmol/l
2.5
2.4
2.18
1095
6903
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
102
188
5.51
52.68
1.1
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
859
5037
1.83
52.60
8.7
7.2
mmol/l
0.9
1.1
0.43
680
3885
(3042631) Mycobacterium sp identified in Specimen
190
572
3.40
51.76
2.5
2.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2206
16565
1.55
51.67
5.1
3.7
ng/l
63.4
81.9
0.22
1692
11276
(3026250) Tacrolimus [Mass/volume] in Blood
105
205
5.20
50.90
33.7
34.7
ug/l
7.2
7.3
0.22
97
182
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1826
13200
1.57
50.29
2.6
2.2
u/l
273.0
219.0
0.49
1728
12401
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
851
5057
1.81
49.65
8.7
7.2
kpa
4.9
5.1
4.40
814
4812
(3027801) Oxygen [Partial pressure] in Arterial blood
850
5055
1.81
49.45
8.7
7.1
kpa
12.4
12.4
0.10
814
4813
(3012501) Base excess in Blood by calculation
269
1015
2.73
49.42
5.2
4.4
mmol/l
2.2
2.6
1.46
195
677
(3013290) Carbon dioxide [Partial pressure] in Blood
269
1016
2.73
49.33
5.2
4.4
kpa
4.8
5.0
5.69
262
995
(3027315) Oxygen [Partial pressure] in Blood
269
1019
2.72
49.05
5.2
4.4
kpa
8.6
8.5
0.24
262
997
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
584
3084
2.00
48.93
5.7
4.4
kpa
5.1
5.1
1.42
552
2862
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
211
701
3.09
48.88
1.2
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
88
153
5.83
48.36
1.1
1.2
—
—
—
0
0
(4062490)
161
455
3.61
48.32
1.5
1.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
275
1063
2.67
48.19
1.5
1.2
u/ml
9.9
3.2
0.44
42
103
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
563
2957
2.01
47.85
5.7
4.4
mmol/l
1.8
1.7
0.39
420
2153
(3009343) pH of Capillary blood
576
3051
1.99
47.79
5.7
4.4
ph
7.4
7.4
1.44
92
339
(3000012) Reticulocyte production index
106
221
4.87
47.65
2.5
1.4
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
159
452
3.59
47.31
1.5
1.4
g/l
2.7
2.9
1.12
121
324
(3024139) IgG subclass 3 [Mass/volume] in Serum
159
452
3.59
47.31
1.5
1.4
g/l
0.4
0.4
0.42
121
322
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
276
1080
2.64
47.19
1.5
1.2
u/ml
14.9
7.1
0.67
58
175
(3027135) IgG subclass 1 [Mass/volume] in Serum
159
453
3.58
47.15
1.5
1.4
g/l
6.8
6.7
0.08
121
325
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
718
4117
1.85
46.87
2.9
2.5
u/l
32.4
49.9
0.86
631
3511
(4212803)
45
35
12.95
46.84
1.1
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
348
1525
2.37
46.72
2.6
2.3
ug/l
415.9
641.0
0.74
326
1430
(3000494) Fungus identified in Specimen by Culture
850
5164
1.76
45.69
1.9
1.5
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
286
1163
2.54
45.18
1.5
1.2
u/ml
38.9
41.9
0.07
28
74
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
45
38
11.93
44.54
1.2
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
63
84
7.57
44.51
1.5
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
389
1832
2.21
43.99
2.1
1.9
u/l
42.5
38.7
2.06
355
1613
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
86
162
5.38
43.41
1.9
2.0
u/ml
6241.6
22160.5
0.37
11
23
(40761536) Microorganisms panel - Urine sediment
663
3793
1.85
43.40
5.7
3.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
308
1322
2.41
43.28
4.0
3.3
—
—
—
0
0
(3010421) pH of Blood
288
1201
2.47
43.11
5.1
4.2
ph
7.4
7.4
2.89
263
995
(3032352) Blasts [#/volume] in Cerebral spinal fluid
48
47
10.29
43.08
3.5
2.6
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
84
156
5.45
43.06
1.2
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
138
385
3.65
42.24
1.1
1.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
226
847
2.74
42.05
1.5
1.2
u/ml
49.5
39.4
0.45
44
88
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
72
118
6.17
42.03
3.2
1.9
e6/l
3721.7
18993.3
0.53
48
71
(40759836) Histone Ab [Presence] in Serum by Immunoblot
121
312
3.94
41.47
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
121
312
3.94
41.47
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
121
312
3.94
41.47
1.2
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
484
2533
2.00
41.34
1.4
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
144
422
3.48
40.93
3.8
2.9
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
121
315
3.90
40.92
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
121
315
3.90
40.92
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
121
315
3.90
40.92
1.2
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
71
118
6.08
40.88
2.9
1.9
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
750
4540
1.75
40.47
9.3
7.5
%
95.3
95.6
0.37
721
4369
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
346
1613
2.22
40.06
1.7
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
120
318
3.84
39.59
2.6
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
1604
11744
1.51
39.57
5.7
4.0
estimate
0.0
0.0
1.49
681
3993
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
223
858
2.67
39.41
1.4
1.2
u/ml
2.4
5.3
0.62
16
67
(3008536) Aspergillus sp Ab [Presence] in Serum
59
84
7.09
39.35
3.8
2.1
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
65
103
6.37
39.23
2.2
1.5
g/l
12.1
12.7
0.15
41
80
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
54
71
7.67
38.62
1.6
2.0
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
74
137
5.46
38.08
3.2
2.1
e6/l
1050.7
5873.5
0.45
60
104
(3002173) Hemoglobin [Mass/volume] in Arterial blood
690
4152
1.76
37.86
9.9
7.9
g/l
114.1
121.7
16.85
671
3999
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
4866
44728
1.72
37.53
32.1
14.1
mg/l
23.2
24.0
1.03
4320
35495
(3015235) Bicarbonate [Moles/volume] in Capillary blood
271
1171
2.38
37.48
4.4
3.5
mmol/l
24.3
24.8
1.06
244
1024
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
402
2037
2.05
37.48
5.4
2.9
%
0.7
0.6
2.17
395
1952
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
73
136
5.43
37.32
4.7
3.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
289
1288
2.31
37.24
5.4
4.8
kpa
8.4
8.5
0.34
270
1202
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
80
163
4.97
36.99
2.8
2.8
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
38
33
11.59
36.92
2.0
5.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
127
368
3.51
36.75
1.4
1.3
titre
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
93
218
4.32
36.23
3.9
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
93
218
4.32
36.23
3.9
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
93
218
4.32
36.23
3.9
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
93
218
4.32
36.23
3.9
1.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
1423
10322
1.51
36.09
4.7
3.6
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
26
11
23.74
36.02
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
26
11
23.74
36.02
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
26
11
23.74
36.02
1.0
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
66
116
5.75
35.90
1.3
1.2
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
88
199
4.48
35.89
1.3
1.1
u/ml
86.3
23.8
—
9
18
(3022493) Free Hemoglobin [Mass/volume] in Plasma
86
191
4.56
35.87
4.0
6.4
mg/l
68.0
70.9
0.14
73
135
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
41
42
9.83
35.63
1.1
1.0
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
125
366
3.47
35.61
2.1
1.9
g/24h
2.0
1.6
—
7
19
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
487
2684
1.89
35.55
2.0
1.7
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
78
161
4.90
35.53
1.1
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
63
108
5.89
35.17
3.0
1.9
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
231
958
2.47
34.97
3.3
2.5
%
15.0
16.3
3.70
117
486
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
85
192
4.48
34.72
1.3
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
138
437
3.21
34.70
1.2
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1302
9352
1.51
34.33
1.8
1.7
pmol/l
6648912.2
32574721.6
2.37
1098
7773
(3039162) Centromere protein B Ab [Units/volume] in Serum
149
498
3.05
34.20
1.5
1.2
u/ml
37.5
46.6
0.14
11
31
(3013862) HLA-DP [Type]
25
11
22.83
34.10
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
25
11
22.83
34.10
1.0
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
209
838
2.55
33.98
3.9
2.9
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
75
156
4.86
33.87
1.1
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
903
5992
1.61
33.85
1.3
1.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
95
239
4.03
33.73
1.2
1.1
ratio
1.2
1.0
1.65
42
83
(3002385) Erythrocyte distribution width [Ratio]
4164
37179
1.48
33.64
37.8
17.0
%
14.3
13.7
96.02
4108
36372
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
80
177
4.57
33.54
4.3
2.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
80
177
4.57
33.54
4.3
2.0
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
164
586
2.85
33.41
1.2
1.1
g/l
1.6
1.5
0.69
156
524
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
80
179
4.52
33.08
4.3
2.0
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
395
2089
1.96
32.56
5.6
2.9
%
1.3
1.2
0.26
395
2073
(3037121) Protein [Mass/volume] in Urine
319
1566
2.10
32.32
4.7
3.4
g/l
0.3
0.3
0.22
201
671
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
2109
16769
1.42
32.22
5.5
3.8
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
153
539
2.89
32.00
2.3
2.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3389
29247
1.41
32.00
4.7
3.1
u/l
66.1
47.8
19.31
3197
27282
(40768446) Kidney Pathology biopsy report
79
182
4.39
31.51
1.6
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
500
2894
1.80
31.06
6.0
4.7
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
53
87
6.14
30.93
1.3
1.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
475
2726
1.81
30.34
6.0
3.4
g/l
119.6
129.2
14.43
467
2649
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
23
11
20.99
30.29
1.0
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
203
851
2.44
30.03
1.6
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
131
442
3.01
29.62
2.0
2.0
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
180
722
2.54
29.26
2.5
1.9
mmol/l
1.9
1.7
1.60
173
705
(3042733) HLA Ab [Presence] in Serum
67
145
4.67
28.89
4.5
4.6
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
50
83
6.07
28.86
1.5
1.4
g/l
16.8
26.0
3.41
36
62
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
169
663
2.60
28.76
1.3
1.3
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
473
2777
1.77
27.92
10.7
8.8
%
1.5
1.3
1.61
465
2758
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
46
73
6.35
27.76
1.5
1.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
202
877
2.35
27.65
1.4
1.2
u/ml
1.3
5.7
—
6
10
(40768441) Liver Pathology biopsy report
106
329
3.27
27.61
1.8
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
98
290
3.42
27.53
1.1
1.0
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
470
2768
1.76
27.43
10.9
8.9
%
0.7
0.7
1.37
462
2745
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1169
8547
1.47
27.32
4.7
3.7
ng/l
446.9
549.3
0.25
927
6659
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
412
2337
1.82
27.28
10.5
9.3
mmol/l
23.8
24.3
2.09
393
2180
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
217
978
2.27
27.23
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
217
978
2.27
27.23
1.4
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
63
137
4.64
27.03
1.1
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1535
11822
1.41
26.98
4.8
3.3
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
152
585
2.64
26.91
1.1
1.1
%
113.2
115.7
0.32
142
533
(3006922) Hepatitis E virus Ab [Presence] in Serum
101
310
3.30
26.79
1.1
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
400
2262
1.83
26.74
6.4
4.6
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
96
288
3.37
26.41
1.1
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
51
96
5.35
25.84
1.2
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
92
275
3.39
25.47
2.2
1.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
122
431
2.87
25.45
1.3
1.2
u/l
77.3
69.2
0.21
96
286
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
76
201
3.82
25.25
2.3
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
76
201
3.82
25.25
2.3
1.4
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
377
2135
1.82
25.06
5.7
3.5
mmol/l
24.8
25.2
1.54
369
2062
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
90
270
3.37
24.78
2.2
1.4
—
—
—
0
0
(4306422)
152
613
2.52
24.48
1.2
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
796
5495
1.52
24.40
2.6
2.4
ug/g
153.1
133.3
0.72
658
4347
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
550
3498
1.64
24.02
4.1
2.6
ml/min/173m2
62.1
65.9
1.27
290
1370
(3003181) Sodium [Moles/volume] in Urine
176
766
2.34
23.99
1.6
1.4
mmol/l
61.7
64.2
0.30
131
619
(40761535) Cells panel - Urine sediment
568
3651
1.62
23.75
4.9
3.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
4846
45431
1.53
23.71
33.3
16.3
mmol/l
139.3
139.6
18.84
4768
44260
(3008152) Bicarbonate [Moles/volume] in Arterial blood
453
2755
1.70
23.48
9.2
6.7
mmol/l
24.7
24.5
0.31
426
2571
(3023103) Potassium [Moles/volume] in Serum or Plasma
4855
45553
1.53
23.45
33.9
16.4
mmol/l
4.0
4.0
0.31
4768
44291
(3012516) Albumin [Mass/volume] in Urine
1602
12665
1.37
23.41
4.1
3.3
mg/l
828.0
326.3
2.66
1147
8105
(3020682) Albumin/Creatinine [Ratio] in Urine
1673
13323
1.37
23.33
5.1
4.0
mg/mmol
16.0
11.2
1.74
1177
8535
(3018405) Lactate [Moles/volume] in Arterial blood
293
1567
1.92
23.30
5.0
3.7
mmol/l
1.4
1.4
0.03
284
1543
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
27
28
9.69
23.21
3.1
1.7
%
64.9
57.4
0.28
15
20
(3017732) Neutrophils [#/volume] in Blood
488
3039
1.66
23.12
3.1
2.8
e9/l
4.4
4.1
0.38
372
2371
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
659
4417
1.56
23.03
3.8
4.0
ug/l
16.5
22.9
0.48
546
3580
(3003694) ABO and Rh group [Type] in Blood
1594
12623
1.37
22.95
1.7
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1722
13809
1.36
22.87
4.3
3.3
mmol/l
7.2
7.6
3.54
1488
11619
(3014148) Varicella zoster virus Ab [Titer] in Serum
142
574
2.51
22.78
1.1
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1302
9998
1.40
22.57
1.4
1.3
u/ml
2.7
1.9
1.05
331
2553
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
269
1415
1.95
22.47
1.6
1.6
iu/ml
1.7
7.4
0.66
74
300
(3000570) Elastase.pancreatic [Mass/mass] in Stool
246
1258
2.00
22.29
1.5
1.4
ug/g
278.3
282.5
0.11
138
714
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
85
267
3.22
21.79
1.6
1.6
u/l
3.8
5.6
0.71
46
129
(40768804) Tissue Pathology biopsy report
2137
17792
1.33
21.76
2.3
2.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
204
984
2.11
21.66
2.5
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
202
971
2.12
21.64
6.1
3.3
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
144
605
2.42
21.28
1.5
1.5
g/l
30.2
32.3
1.21
133
547
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
101
356
2.87
21.22
1.1
1.0
mg/l
299.2
290.5
0.42
94
317
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
988
7299
1.43
21.20
1.3
1.3
iu/ml
36.1
30.9
0.37
310
2244
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
116
441
2.67
21.11
1.2
1.1
%
89.6
95.4
1.42
111
417
(3034426) Prothrombin time (PT)
57
140
4.10
21.01
1.3
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
60
154
3.93
20.84
1.3
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
755
5326
1.48
20.60
2.0
1.7
%
1.7
1.5
4.06
630
4709
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
18
12
15.05
20.20
1.0
1.0
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
205
1018
2.05
20.17
2.7
2.2
g/l
118.4
129.1
6.67
158
733
(3020891) Body temperature
308
1759
1.80
19.89
6.7
4.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
381
2312
1.70
19.86
4.1
2.8
e6/l
0.3
0.3
0.33
370
2253
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
143
622
2.33
19.58
1.1
1.1
—
—
—
0
0
(4281824)
105
396
2.68
19.45
1.4
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
143
625
2.32
19.37
1.1
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
44
94
4.71
19.35
1.7
1.3
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
182
878
2.11
19.35
3.0
3.5
u/ml
710.4
773.2
0.04
157
814
(3002621) Streptococcal DNAse B [Units/volume] in Serum
31
48
6.49
19.17
1.1
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
155
706
2.23
19.05
1.2
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
337
2005
1.72
18.88
6.9
4.9
mmol/l
24.8
24.7
0.55
319
1858
(3013139) Helicobacter pylori Ag [Presence] in Stool
449
2883
1.61
18.74
1.2
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
644
4483
1.49
18.67
1.7
1.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
81
272
3.01
18.60
4.2
3.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
129
549
2.38
18.58
3.0
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
115
466
2.50
18.43
1.5
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
177
864
2.08
18.26
1.6
1.3
—
—
—
0
0
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
22
24
9.20
18.20
3.4
1.5
%
10.8
17.8
—
10
13
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
56
151
3.74
18.19
1.2
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
128
552
2.35
17.91
1.2
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
674
4773
1.47
17.89
1.4
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
321
1913
1.72
17.88
3.2
1.9
—
—
—
0
0
(3017704) Immunofixation for Urine
71
226
3.17
17.87
1.8
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
127
547
2.35
17.82
3.1
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
129
560
2.33
17.78
3.0
1.4
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
44
102
4.34
17.53
1.8
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
224
1207
1.89
17.45
1.3
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
127
553
2.33
17.39
3.1
1.4
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
19
18
10.59
17.32
1.2
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
161
775
2.11
17.25
4.1
3.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
126
549
2.33
17.23
3.1
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
239
1322
1.84
17.16
1.4
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
126
551
2.32
17.09
3.1
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
236
1307
1.84
16.88
1.4
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
109
450
2.45
16.82
4.0
3.3
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
15
10
15.04
16.75
1.1
1.0
—
—
—
0
0
(3036603) Volume of Urine
79
280
2.85
16.52
1.6
1.4
ml
1821.2
1873.9
0.10
18
66
(42529406) Shigella sp [Presence] in Stool by Culture
237
1330
1.82
16.25
1.4
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
31
57
5.46
16.16
1.9
1.6
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
123
546
2.28
16.13
1.5
1.4
e6/l
2295.7
2223.7
0.03
102
400
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
243
1379
1.80
16.06
1.2
1.3
miu/ml
218.6
222.5
0.05
92
638
(3043409) Potassium [Moles/volume] in Arterial blood
236
1328
1.81
16.04
5.4
3.9
mmol/l
3.9
3.9
0.29
214
1241
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
43
105
4.12
16.04
1.2
1.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
418
2744
1.57
15.84
1.4
1.3
u/ml
339.6
218.7
1.42
372
2527
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
88
339
2.62
15.71
1.3
1.1
—
33.6
—
0
5
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
4393
41147
1.33
15.59
27.2
13.1
ml/min/173m2
80.0
81.6
3.92
3884
33865
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
19
21
9.08
15.54
1.2
1.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
549
3840
1.48
15.43
2.7
2.3
ug/l
7.5
7.4
0.05
485
3340
(3001686) Cold agglutinin [Titer] in Serum or Plasma
36
79
4.58
15.37
1.3
1.3
titre
109.8
97.9
—
8
14
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
30
57
5.29
15.11
1.4
1.9
—
—
—
0
0
(3044889) 12 lead EKG panel
3354
30416
1.26
15.04
4.7
3.7
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
260
1535
1.73
15.00
3.6
3.4
u/ml
542.0
3552.9
0.96
221
1308
(3047189) Immunofixation for 24 hour Urine
63
208
3.05
14.97
1.5
1.6
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
48
134
3.60
14.88
1.7
1.7
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
24
38
6.34
14.54
1.6
2.6
mg/l
1.9
1.8
0.02
14
27
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
97
410
2.39
14.28
1.5
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
3696
33990
1.26
14.28
4.3
3.9
pmol/l
14.8
14.8
0.35
3417
30900
(40768806) Pleura Pathology biopsy report
108
479
2.28
14.24
1.6
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
366
2389
1.57
14.22
13.0
9.9
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
20
9
22.30
14.19
1.1
1.0
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
110
493
2.26
14.16
1.5
1.4
e6/l
66747.4
74446.9
0.07
71
292
(3035880) pH of Pleural fluid
68
243
2.82
14.06
1.5
1.3
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
34
77
4.44
13.99
7.1
7.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
46
132
3.51
13.71
1.3
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
113
520
2.20
13.66
1.3
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
188
1041
1.83
13.51
1.3
1.2
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
61
210
2.93
13.51
1.2
1.1
u/l
89.2
90.5
0.05
54
161
(3036782) Glucose [Moles/volume] in Pleural fluid
99
433
2.31
13.51
1.4
1.4
mmol/l
5.9
6.5
1.18
93
402
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
352
2309
1.56
13.38
2.4
2.4
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
18
23
7.85
13.14
1.3
1.3
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
179
985
1.84
13.14
2.4
1.5
e6/l
45.3
26.1
0.23
151
762
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
179
987
1.84
13.05
2.5
1.5
e6/l
600.9
5047.9
0.64
156
804
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
527
3779
1.44
12.95
3.4
3.0
ng/l
300.6
205.6
3.94
483
3441
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
60
210
2.88
12.92
1.2
1.1
u/l
28.8
29.6
0.05
48
157
(3027456) Digoxin [Moles/volume] in Serum or Plasma
163
878
1.88
12.80
2.9
3.1
nmol/l
0.8
0.8
0.52
114
659
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
278
1754
1.62
12.48
2.3
1.8
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
32
77
4.17
12.22
1.4
1.8
—
—
—
0
0
(3016750) Collection duration of Urine
65
247
2.65
12.01
2.4
2.2
min
524.4
490.9
1.53
43
187
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1028
8283
1.30
11.88
1.6
1.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4915
47210
1.37
11.76
20.3
10.1
u/l
27.6
26.3
2.06
4818
45483
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
20
33
6.08
11.65
1.8
1.5
mg/l
1.0
1.0
0.02
13
21
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
20
33
6.08
11.65
1.8
1.5
mg/l
1.1
1.8
0.28
14
25
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
20
33
6.08
11.65
1.8
1.5
mg/l
0.7
1.5
0.59
14
23
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
20
33
6.08
11.65
1.8
1.5
mg/l
1.5
1.7
0.09
13
26
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
20
33
6.08
11.65
1.8
1.5
mg/l
1.1
3.1
0.97
12
19
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
20
33
6.08
11.65
1.8
1.5
mg/l
2.8
0.9
0.61
12
24
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
20
33
6.08
11.65
1.8
1.5
mg/l
1.2
1.2
0.01
15
19
(3044290) Cell count panel - Cerebral spinal fluid
164
914
1.82
11.60
2.5
1.5
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
15
18
8.35
11.49
1.0
1.1
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
29
68
4.28
11.46
2.6
3.1
mg/l
62.8
17.4
—
5
15
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
869
6880
1.31
11.40
1.3
1.2
u/ml
10.6
12.2
0.26
285
2682
(40761539) Cells [Type] in Urine sediment by Light microscopy
38
109
3.50
11.39
1.2
1.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
45
144
3.14
11.35
2.2
2.1
ug/l
80.7
62.5
0.45
45
139
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
20
34
5.90
11.31
1.8
1.5
mg/l
2.0
1.4
0.17
11
23
(3009542) Hematocrit [Volume Fraction] of Blood
4340
41046
1.27
11.30
30.4
15.1
%
38.4
39.7
16.89
3048
29743
(3045788) Cell count panel - Pleural fluid
92
426
2.18
11.03
1.5
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
262
1685
1.58
10.89
2.4
2.7
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
39
119
3.29
10.65
1.2
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
34
95
3.59
10.61
2.1
2.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
101
493
2.07
10.59
1.1
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
4831
46425
1.32
10.36
28.6
13.2
—
—
—
0
0
(3002256) Pathology report gross observation
732
5735
1.32
10.30
1.3
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
327
2237
1.49
10.26
4.6
3.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
51
186
2.76
10.25
1.0
1.1
miu/ml
1369.8
1489.1
0.33
51
186
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
23
49
4.71
10.22
1.3
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
90
430
2.11
10.01
1.5
1.2
—
—
—
0
0
(3013512) EKG study
1462
12493
1.23
10.00
4.7
3.9
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
139
773
1.82
9.96
1.6
1.5
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
24
55
4.38
9.78
8.6
12.1
mmol/l
7.9
6.1
0.43
24
55
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
4279
40589
1.24
9.77
5.2
4.7
mu/l
2.0
2.1
0.84
4007
37210
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
72
318
2.28
9.72
1.4
1.3
u/l
14.0
13.1
0.17
66
291
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
32
93
3.46
9.45
3.7
2.4
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
41
139
2.96
9.43
1.7
1.4
%
1.7
2.8
0.59
36
118
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
63
266
2.38
9.43
1.3
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1142
9569
1.24
9.28
5.6
4.0
kg/l
1.0
1.0
0.33
172
1453
(3020961) Endomysium IgA Ab [Titer] in Serum
312
2172
1.46
8.99
1.2
1.1
titre
85.0
158.0
—
10
55
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
15
24
6.26
8.98
3.5
5.7
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
24
59
4.08
8.96
1.2
1.0
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
164
989
1.68
8.89
2.3
1.3
mmol/l
3.8
3.8
0.43
154
926
(3011325) HIV 1+2 Ab [Presence] in Serum
14
21
6.68
8.89
1.0
1.0
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
18
35
5.16
8.87
1.5
1.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
73
338
2.18
8.84
2.4
2.3
ml
779.7
618.7
1.59
50
225
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
3136
29000
1.19
8.82
3.4
3.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
85
419
2.04
8.75
1.4
1.4
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
17
32
5.33
8.67
1.5
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
194
1231
1.60
8.61
1.5
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
482
3647
1.35
8.57
1.2
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
288
1994
1.47
8.55
2.0
1.9
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
265
1806
1.49
8.51
7.2
5.2
%
0.9
0.9
0.34
246
1696
(3019225) pH of Specimen
566
4390
1.32
8.51
7.8
4.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
91
466
1.97
8.45
2.4
1.5
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
73
345
2.13
8.41
1.3
1.2
u/ml
59.5
54.2
—
5
18
(3016038) Potassium [Moles/volume] in Urine
64
289
2.23
8.26
2.1
1.3
mmol/l
34.6
34.7
0.02
57
253
(3043410) Blood group antigens tested for on Red Blood Cells
36
123
2.94
8.21
2.5
1.7
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
99
528
1.89
8.17
3.9
2.3
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
25
68
3.69
8.16
2.1
2.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
107
586
1.84
8.13
1.7
1.6
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
68
318
2.15
8.07
1.2
1.2
u/ml
36.8
3.3
—
5
17
(3035285) Chloride [Moles/volume] in Venous blood
100
539
1.87
7.99
3.9
2.3
mmol/l
105.5
105.5
0.02
100
530
(3041354) Potassium [Moles/volume] in Venous blood
100
539
1.87
7.99
3.9
2.3
mmol/l
4.1
4.1
0.45
100
530
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
185
1185
1.58
7.92
1.3
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
224
1498
1.52
7.91
1.8
1.7
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
44
172
2.57
7.82
1.7
1.4
%
60.8
65.4
0.40
38
139
(1761482) Bacteria [#/volume] in Urine by Culture
175
1110
1.60
7.81
5.3
4.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
76
378
2.02
7.69
7.9
3.2
%
10.3
11.1
1.14
76
378
(3004716) Salmonella sp identified in Stool by Organism specific culture
322
2328
1.41
7.59
1.4
1.3
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
38
141
2.71
7.49
1.4
1.2
%
26.8
21.5
—
10
19
(3026389) Candida sp identified in Specimen by Organism specific culture
107
603
1.79
7.44
1.2
1.3
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
69
336
2.07
7.41
1.3
1.2
u/ml
78.0
55.6
—
5
14
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
61
284
2.16
7.35
2.1
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
178
1154
1.56
7.26
1.3
1.4
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
69
339
2.05
7.24
1.3
1.2
u/ml
31.8
53.3
—
5
27
(3000475) Leukocytes [#/volume] in Synovial fluid
160
1015
1.59
7.17
1.6
1.6
e6/l
16233.4
12951.8
0.50
121
727
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
288
2073
1.41
6.98
7.0
3.2
u/ml
92.9
54.4
1.07
279
2000
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
14
27
5.20
6.96
2.0
5.0
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
200
1347
1.50
6.87
1.5
1.5
u/l
11.2
9.0
1.31
157
1083
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
257
1823
1.43
6.77
7.1
5.2
%
1.7
1.6
0.41
238
1707
(3052592) Norovirus Ag [Presence] in Stool
25
78
3.22
6.68
1.6
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
42
174
2.42
6.66
1.2
1.3
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
64
317
2.03
6.61
1.8
1.5
u/ml
20.7
21.2
0.03
18
60
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
49
220
2.24
6.49
1.7
1.3
%
59.2
65.9
—
6
30
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
11
18
6.12
6.42
2.2
1.6
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
53
249
2.14
6.30
1.5
1.6
u/l
5.6
6.9
0.82
44
217
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
57
276
2.08
6.27
1.4
1.2
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
15
34
4.42
6.23
1.1
1.3
ml/s/173m2
1.9
1.0
—
9
27
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
81
445
1.83
6.19
3.5
3.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
309
4098
0.74
6.15
1.2
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
113
685
1.66
6.14
1.5
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
57
279
2.05
6.10
1.4
1.2
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
30
110
2.74
6.10
1.1
1.1
—
296.0
—
0
5
(44806071)
18
48
3.76
6.08
1.1
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
53
254
2.10
6.01
3.9
2.6
ph
7.4
7.4
1.83
24
87
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
38
159
2.40
5.94
1.0
1.1
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
27
95
2.85
5.93
3.6
3.3
u/l
45.4
81.1
—
9
30
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
41
180
2.29
5.77
1.1
1.1
%
88.4
93.9
0.57
33
140
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
12
24
5.01
5.74
1.0
1.0
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
115
714
1.62
5.71
1.2
1.1
au/ml
2.8
12.0
—
5
46
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
44
201
2.20
5.64
1.1
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
49
234
2.10
5.63
3.6
3.0
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
83
474
1.76
5.62
1.6
1.4
mosm/kgh2o
278.3
279.0
0.10
70
355
(3046861) Legionella sp Ag [Presence] in Urine
10
17
5.89
5.62
1.0
1.0
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
89
520
1.72
5.57
8.0
5.3
mmol/l
8.3
7.3
0.25
73
432
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
72
395
1.83
5.57
1.5
1.5
%
22.7
31.5
1.35
47
238
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
12
25
4.81
5.49
1.2
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
35
147
2.39
5.45
1.0
1.1
—
—
—
0
0
(4010399)
386
3023
1.30
5.45
1.5
1.4
—
—
—
0
0
(3019174) dRVVT (LA screen)
15
38
3.96
5.43
1.3
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
49
238
2.07
5.40
2.3
2.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
16
43
3.73
5.36
1.1
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
71
395
1.81
5.27
1.2
1.1
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
11
22
5.01
5.26
2.2
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
103
637
1.63
5.23
1.3
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
293
3814
0.76
5.15
1.9
1.7
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
56
291
1.93
5.14
1.3
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
238
1755
1.37
5.09
2.1
2.3
u/l
4292.2
5952.8
0.38
87
685
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
86
512
1.69
5.07
1.6
1.6
%
66.4
59.5
0.93
53
322
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
10
19
5.27
5.04
1.0
1.4
—
—
—
0
0
(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid
12
27
4.45
5.03
1.1
1.3
u/l
20.3
3084.0
0.56
12
22
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
12
27
4.45
5.03
4.8
6.2
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
12
27
4.45
5.03
4.7
5.6
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
11
23
4.79
5.01
1.5
1.9
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
103
646
1.61
4.97
1.1
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
115
743
1.56
4.90
1.6
1.5
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
68
384
1.78
4.84
1.3
1.2
nmol/l
317.1
357.1
0.80
57
330
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
19
62
3.07
4.78
1.4
1.3
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
84
506
1.67
4.76
1.2
1.1
iu/ml
1.1
2.5
—
6
7
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
47
237
1.99
4.73
1.1
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
150
1036
1.46
4.67
2.3
2.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
337
2653
1.29
4.61
3.5
3.3
pmol/l
4.4
4.5
1.23
303
2348
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
60
335
1.80
4.46
1.2
1.2
—
—
—
0
0
(3025315) Body weight
12
30
4.01
4.43
4.8
3.9
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
20
71
2.82
4.38
1.9
1.4
%
7.5
6.7
0.08
13
36
(3022621) pH of Urine by Test strip
365
2934
1.26
4.24
2.9
3.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
13
36
3.62
4.20
1.3
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
44
227
1.95
4.19
2.3
2.3
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
45
236
1.91
4.09
1.6
1.7
u/field
1.8
3.6
0.89
36
168
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
10
8.01
4.06
1.0
1.0
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
15
47
3.20
4.05
1.0
1.2
u/l
20.1
19.2
—
9
31
(3028707) Methadone [Presence] in Urine by Screen method
119
811
1.48
4.02
4.3
2.9
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
92
595
1.56
3.98
1.9
2.4
umol/l
9.4
8.1
0.32
76
427
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
148
1054
1.42
3.97
2.8
2.4
ug/min
164.1
105.1
0.98
93
654
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
25
105
2.39
3.97
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
25
105
2.39
3.97
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
25
105
2.39
3.97
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
25
105
2.39
3.97
1.1
1.1
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
19
70
2.72
3.91
1.1
1.4
nmol/l
7.2
138603.4
0.49
14
57
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
42
219
1.92
3.90
4.1
3.7
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
10
24
4.17
3.88
1.5
1.5
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
187
1391
1.36
3.87
9.1
6.1
mmol/l
1.3
1.3
0.18
157
1224
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
8
11
7.28
3.85
3.3
3.6
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
6
5
12.01
3.76
1.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
28
127
2.21
3.75
1.5
1.4
ug/l
10.6
8.7
0.75
28
127
(3002619) Bacteria identified in Specimen by Culture
22
90
2.45
3.71
1.3
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
45
246
1.84
3.65
1.1
1.1
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
11
30
3.67
3.63
1.0
1.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
332
2696
1.25
3.57
1.4
1.3
au/ml
22.6
54.1
—
9
121
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
72
452
1.60
3.57
1.0
1.1
—
41.3
—
0
6
(3014891) Appearance of Pleural fluid
18
68
2.65
3.55
1.4
1.6
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
23
99
2.33
3.49
1.6
1.6
ug/l
0.4
0.4
0.02
16
61
(40757494) Bilirubin.total [Moles/volume] in Blood
46
258
1.79
3.45
2.6
2.9
umol/l
57.1
38.9
—
7
26
(3023410) Appearance of Cerebral spinal fluid
71
452
1.58
3.34
3.6
1.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
67
421
1.60
3.33
1.0
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
358
2956
1.23
3.32
2.5
2.4
au/ml
28.0
23.6
—
10
169
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
31
155
2.01
3.29
2.4
2.5
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
48
279
1.73
3.22
1.5
1.4
titre
124.0
419.6
—
5
27
(3004451) EKG impression Narrative
38
207
1.84
3.16
1.4
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
33
172
1.92
3.13
1.5
1.5
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
18
73
2.47
3.12
1.1
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
30
152
1.98
3.09
1.2
1.2
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
11
34
3.24
3.05
8.5
3.9
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
10
29
3.45
3.04
1.1
1.0
—
—
—
0
0
(4198724)
38
210
1.82
3.03
2.0
2.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
5047
49686
1.18
3.02
47.3
20.6
e9/l
200.3
250.8
258.18
4961
48383
(3010813) Leukocytes [#/volume] in Blood
5051
49729
1.18
3.02
47.3
20.6
e9/l
6.8
6.8
0.09
4962
48285
(3039000) Anion gap in Blood
133
980
1.37
3.01
10.9
7.1
mmol/l
11.1
11.3
0.39
115
878
(3024731) MCV [Entitic volume]
5049
49711
1.18
3.00
47.1
20.5
fl
91.5
90.8
16.35
5000
48985
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
202
2559
0.78
2.99
1.5
1.4
—
—
—
0
0
(3000492) Spirometry study
483
4145
1.18
2.99
1.5
1.4
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
133
981
1.36
2.99
10.9
7.1
mmol/l
105.0
105.1
0.10
115
879
(3035941) MCH [Entitic mass]
5049
49712
1.18
2.99
47.0
20.5
pg
30.4
30.3
2.99
5000
48985
(3036525) Urea [Moles/time] in 24 hour Urine
9
21
4.29
2.99
1.9
3.4
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
12
40
3.00
2.97
2.1
2.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
18
75
2.40
2.96
1.8
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
18
75
2.40
2.96
1.9
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
18
75
2.40
2.96
1.9
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
5049
49719
1.18
2.95
47.2
20.6
e12/l
4.3
4.5
117.95
4957
48283
(3000963) Hemoglobin [Mass/volume] in Blood
5050
49732
1.18
2.93
47.5
20.7
g/l
128.4
135.3
149.66
4998
49010
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
11
35
3.15
2.93
1.2
1.1
—
24.8
—
0
8
(3002523) Influenza virus A Ag [Presence] in Specimen
98
692
1.42
2.86
1.2
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
25
122
2.05
2.86
1.2
1.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
49
297
1.66
2.86
1.1
1.1
iu/ml
12.5
11.0
0.13
15
74
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
71
471
1.51
2.84
1.0
1.1
—
3.5
—
0
9
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
28
143
1.96
2.84
1.1
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
50
306
1.64
2.81
1.5
1.3
u/ml
0.3
1.0
1.07
27
132
(3018738) Hemoglobin F/Hemoglobin.total in Blood
11
36
3.06
2.80
2.2
4.0
%
7.0
4.3
—
6
14
(3013945) Hepatitis B virus e Ab [Presence] in Serum
9
23
3.92
2.77
1.6
1.9
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
97
690
1.41
2.73
1.2
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
48
294
1.64
2.71
1.1
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
60
906
0.66
2.69
1.2
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
52
326
1.60
2.68
3.0
2.3
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
161
1245
1.30
2.67
1.1
1.1
u/ml
2.4
5.2
1.50
13
156
(3029396) Erythrocyte agglutination [Presence] in Blood
24
119
2.02
2.65
2.3
3.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
9
25
3.60
2.57
1.0
1.0
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
31
171
1.82
2.53
2.9
4.0
mg/l
8.2
8.1
0.03
22
140
(3023323) Follitropin [Units/volume] in Serum or Plasma
241
1973
1.23
2.50
1.4
1.4
iu/l
26.3
25.9
0.06
199
1666
(3028679) Herpes simplex virus Ab [Presence] in Serum
40
240
1.67
2.46
1.1
1.2
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
24
123
1.96
2.44
1.4
1.2
ug/l
282.6
426.1
0.16
14
61
(3042010) Triglyceride [Moles/volume] in Pleural fluid
17
76
2.24
2.43
1.2
1.2
mmol/l
3.0
1.8
—
10
54
(3034891) Synovial lining cells/100 cells in Synovial fluid
35
204
1.72
2.40
1.4
1.5
%
3.8
4.1
—
9
41
(3020191) Ethanol [Moles/volume] in Serum or Plasma
56
368
1.53
2.39
2.0
1.4
promille
0.9
1.3
1.10
45
288
(3011985) Renin [Units/volume] in Plasma
81
574
1.42
2.38
1.6
1.5
mu/l
112.5
58.0
0.74
76
507
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
34
198
1.72
2.34
1.8
2.5
umol/l
76.8
154.3
1.78
16
115
(40757373) Influenza virus identified in Isolate
20
98
2.04
2.31
1.3
1.5
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
26
143
1.82
2.18
1.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
11
42
2.62
2.18
1.1
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
344
2958
1.17
2.15
1.3
1.2
iu/ml
128.2
148.4
0.47
123
1061
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
7
19
3.69
2.15
1.1
1.2
—
—
—
0
0
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
7
19
3.69
2.15
1.6
1.1
u/field
1.3
1.0
—
7
13
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
122
940
1.30
2.14
1.5
1.5
pmol/l
139.5
165.0
0.37
117
918
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
13
56
2.32
2.04
1.8
1.6
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
29
169
1.72
2.03
1.2
1.1
ng/l
3987.1
382.7
—
10
37
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
9
32
2.82
2.00
1.2
1.3
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
7
21
3.34
1.96
15.6
5.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
57
395
1.45
1.94
1.2
1.3
e6/l
191709.0
97334.4
0.33
45
274
(3032641) Amino acids panel - Urine
5
11
4.55
1.94
1.4
1.2
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
34
210
1.62
1.94
2.7
2.3
umol/l
58.1
53.5
0.31
27
173
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
75
547
1.38
1.93
2.9
2.1
mg/l
31.9
21.9
0.40
15
141
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
36
227
1.59
1.90
1.4
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
148
1190
1.25
1.89
1.8
1.8
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
7
22
3.18
1.88
1.0
1.0
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
87
653
1.34
1.87
5.2
5.1
umol/l
395.0
362.9
1.21
74
568
(3020123) Porphyrins [Interpretation] in Serum or Plasma
8
28
2.86
1.86
1.1
1.0
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
20
107
1.87
1.85
6.5
6.2
%
55.1
73.9
1.15
14
87
(3050794) Legionella sp Ab [Presence] in Serum
10
40
2.50
1.83
1.1
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
35
222
1.58
1.81
2.3
2.2
mmol/l
8.6
9.1
0.53
29
176
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
24
138
1.74
1.79
5.0
2.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
24
138
1.74
1.79
5.0
2.4
—
—
—
0
0
(4027681)
42
279
1.51
1.78
1.3
1.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
15
74
2.03
1.74
1.9
1.9
ng/l
138.6
138.9
0.00
15
74
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
9
36
2.50
1.73
4.9
3.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
388
3431
1.14
1.72
2.2
2.2
nmol/l
12.3
12.4
0.10
332
3005
(4094501)
88
1138
0.77
1.67
1.1
1.1
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
18
97
1.86
1.65
1.5
1.8
nmol/l
0.1
0.2
0.09
12
72
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
591
5378
1.11
1.63
13.6
7.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
119
955
1.25
1.59
1.8
1.7
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
52
370
1.41
1.59
1.2
1.1
mg/l
49.4
42.0
0.41
41
302
(3001019) Free T4 and TSH panel - Serum or Plasma
185
2192
0.84
1.59
1.7
1.7
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
41
279
1.47
1.58
1.4
1.2
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
17
92
1.85
1.55
1.1
1.0
—
—
—
0
0
(4211845)
37
249
1.49
1.52
2.5
3.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
112
901
1.25
1.49
1.3
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
170
1430
1.19
1.47
3.3
2.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
7
28
2.50
1.45
1.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
7
28
2.50
1.45
1.0
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
20
117
1.71
1.44
10.3
6.7
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
23
140
1.65
1.44
1.7
1.1
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
24
148
1.62
1.43
2.5
2.8
umol/l
26.1
29.4
0.67
15
108
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
71
542
1.31
1.43
1.4
1.3
pmol/l
462.6
280.3
0.52
59
416
(44813793)
42
294
1.43
1.43
1.0
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
9
39
2.31
1.43
1.1
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
22
133
1.66
1.42
1.7
1.2
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
16
88
1.82
1.41
3.4
2.2
mmol/l
7.9
7.7
—
9
47
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
49
355
1.38
1.39
1.1
1.1
mg/l
267.5
278.1
0.11
42
301
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
20
119
1.68
1.37
1.0
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
31
206
1.51
1.37
3.2
2.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
72
555
1.30
1.37
1.4
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
35
239
1.47
1.36
1.5
1.8
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
21
127
1.66
1.36
1.0
1.1
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
5
17
2.94
1.36
1.2
1.1
nmol/l
193.6
268.5
—
5
17
(3039443) Prostate specific Ag panel - Serum or Plasma
60
789
0.76
1.35
1.8
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
198
1703
1.17
1.34
3.0
2.2
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
9
42
2.14
1.33
2.1
2.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
47
342
1.38
1.31
1.1
1.1
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
78
612
1.28
1.31
1.4
1.3
nmol/l
0.3
0.3
—
7
33
(3013336) Amino acids [Identifier] in Serum or Plasma
6
24
2.50
1.30
5.5
2.5
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
21
129
1.63
1.29
1.0
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
33
226
1.46
1.28
2.6
3.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
43
310
1.39
1.27
1.1
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
12
62
1.94
1.27
1.0
1.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
54
405
1.34
1.26
4.0
3.1
mg/l
53.0
35.9
0.31
42
304
(3021387) Prolactin [Units/volume] in Serum or Plasma
190
1641
1.16
1.24
1.8
1.6
mu/l
332.4
298.8
0.62
171
1491
(1002224) Polysomnography panel
195
1690
1.16
1.22
1.1
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
23
147
1.57
1.22
1.8
1.9
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
77
610
1.27
1.22
1.4
1.3
nmol/l
0.6
0.6
0.03
77
582
(3010937) Rubella virus Ab [Presence] in Serum
6
26
2.31
1.18
1.2
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
75
596
1.26
1.17
1.5
1.6
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
11
57
1.93
1.17
1.2
1.2
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
34
0.00
1.16
0.0
1.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1535
14720
1.06
1.15
4.5
5.0
ug/l
3.0
3.7
0.55
1350
13188
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
5
20
2.50
1.15
6.6
9.8
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
29
199
1.46
1.14
8.6
12.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1458
15209
0.94
1.14
3.0
2.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
206
1805
1.15
1.13
2.9
2.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
14
80
1.75
1.12
2.1
1.7
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
14
80
1.75
1.12
1.1
1.0
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
75
602
1.25
1.09
1.4
1.4
u/l
28.9
24.1
0.52
59
504
(3001729) Color of Synovial fluid
8
41
1.95
1.08
1.1
1.4
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
11
59
1.87
1.07
1.0
1.2
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
7
33
2.12
1.05
1.1
1.1
—
—
—
0
0
(4015189)
18
113
1.59
1.05
3.3
2.3
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
5
22
2.27
1.03
2.4
2.5
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
109
919
1.19
1.00
1.8
1.9
pmol/l
190.1
200.0
0.38
102
863
(3000764) Benzodiazepines [Presence] in Urine
206
1826
1.13
0.99
3.0
2.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
9
49
1.84
0.98
3.2
2.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
4047
39898
1.05
0.98
6.5
5.7
mmol/mol
39.7
39.7
0.06
3747
36947
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
26
181
1.44
0.98
1.1
1.1
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
15
92
1.63
0.97
2.1
1.8
ug/l
5.1
1.8
—
10
48
(3004446) Plasmodium sp identified in Blood by Light microscopy
8
42
1.91
0.88
2.9
2.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
206
1843
1.12
0.88
3.0
2.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
27
194
1.39
0.88
1.0
1.1
—
—
—
0
0
(44806420)
7
130
0.54
0.87
2.3
2.3
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
16
103
1.56
0.87
10.9
7.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
8
43
1.86
0.87
1.0
1.1
umol/24h
1.7
1.8
—
8
43
(3027570) Oxalate [Moles/time] in 24 hour Urine
6
30
2.00
0.87
1.0
1.3
umol/24h
332.5
347.1
—
6
30
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
265
2407
1.11
0.86
1.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
205
1837
1.12
0.85
3.0
2.1
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
22
153
1.44
0.85
1.0
1.1
u/ml
0.9
28.1
0.70
15
89
(3022689) Creatine [Moles/volume] in Urine
18
120
1.50
0.85
2.6
1.5
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
6
31
1.94
0.84
1.0
1.1
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
6
31
1.94
0.84
4.3
2.6
mg/l
3.0
3.1
—
6
31
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
239
2166
1.11
0.82
1.6
1.5
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
79
662
1.20
0.82
1.8
1.5
nmol/l
0.6
0.4
0.33
56
527
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
70
580
1.21
0.81
1.7
1.3
ug/l
3.8
4.0
0.13
62
520
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
53
427
1.24
0.80
3.0
2.5
nmol/l
18.3
20.0
0.67
46
406
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
78
655
1.19
0.80
1.1
1.1
u/ml
6.6
3.5
0.33
23
299
(3015183) Erythrocyte sedimentation rate
31
233
1.33
0.79
1.1
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
48
1.67
0.78
1.0
1.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
145
1281
1.14
0.78
1.6
1.8
nmol/l
44.0
40.9
0.77
140
1237
(3003338) MCHC [Mass/volume]
3866
38158
1.04
0.77
39.7
17.9
g/l
331.3
332.6
13.54
3835
37831
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
142
1604
0.88
0.77
1.9
1.7
mg/l
6.0
3.9
0.56
105
1130
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
33
252
1.31
0.76
2.6
1.7
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
10
59
1.70
0.75
1.1
1.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
45
359
1.26
0.75
2.7
2.1
u/field
1.9
1.9
0.01
23
137
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1135
11781
0.95
0.74
4.0
4.3
%
23.8
21.9
3.17
531
5797
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
9
55
1.64
0.73
3.1
2.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
9
55
1.64
0.73
2.1
1.6
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
5
25
2.00
0.72
4.6
9.9
e6/l
44.8
137.5
—
5
17
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
18
125
1.44
0.72
1.1
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
10
60
1.67
0.72
1.1
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
10
60
1.67
0.72
1.0
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
139
1236
1.13
0.70
7.7
3.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
31
239
1.30
0.69
1.3
2.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
11
69
1.60
0.68
1.2
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
63
532
1.19
0.64
1.5
1.7
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
5
29
1.72
0.64
1.0
1.3
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
32
251
1.28
0.64
1.1
1.1
u/l
1.1
1.1
0.06
13
123
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
30
234
1.28
0.62
1.2
1.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
17
121
1.41
0.62
1.1
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
49
1.63
0.62
1.0
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
46
379
1.22
0.61
1.3
1.3
mmol/l
11.9
12.0
0.03
16
98
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
472
4468
1.06
0.61
1.5
1.5
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
12
80
1.50
0.59
1.3
2.8
mmol/l
0.6
1.6
—
7
59
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
48
399
1.20
0.59
3.8
4.9
u/ml
38.0
68.9
0.79
17
112
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
15
209
0.72
0.59
1.2
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
16
114
1.40
0.58
1.2
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
4349
43848
0.96
0.57
5.1
4.7
mmol/l
2.6
2.7
28.83
4013
40393
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
93
820
1.14
0.57
1.4
1.5
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
16
115
1.39
0.56
1.3
1.3
%
31.3
32.3
—
10
80
(3005011) Chlamydia sp Ab [Titer] in Serum
11
73
1.51
0.56
1.4
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
116
1039
1.12
0.56
1.5
1.5
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
49
578
0.85
0.53
1.4
1.3
mmol/l
6.9
7.3
0.32
38
424
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
46
545
0.84
0.52
1.1
1.1
u/ml
0.2
0.3
—
10
151
(3006653) Thiamine [Moles/volume] in Blood
29
232
1.25
0.52
1.1
1.3
nmol/l
134.6
133.9
0.02
29
232
(3008116) Ketones [Moles/volume] in Urine by Test strip
14
100
1.40
0.51
1.2
1.4
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
24
188
1.28
0.51
2.1
3.0
ug/l
1.1
1.4
0.43
24
175
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
9
65
1.39
0.50
1.1
2.2
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
7
45
1.56
0.49
1.6
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
4256
42231
1.03
0.48
5.1
4.5
mmol/l
6.0
5.9
2.15
3915
38456
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
13
93
1.40
0.48
1.1
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
15
111
1.35
0.46
1.1
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
16
120
1.33
0.46
1.1
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
49
1.43
0.46
1.0
1.0
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
7
49
1.43
0.46
1.1
1.3
—
640.5
—
0
9
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
102
921
1.11
0.45
1.8
2.0
nmol/l
0.9
0.8
0.70
86
770
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
29
238
1.22
0.44
2.4
2.1
ug/min
47.5
236.8
—
6
61
(3036670) Protein [Mass/volume] in Synovial fluid
17
130
1.31
0.43
1.2
1.2
g/l
36.2
39.0
—
8
69
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
27
328
0.82
0.42
1.3
1.4
pmol/l
71.4
143.6
0.38
12
108
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
288
3042
0.94
0.42
2.3
2.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
8
56
1.43
0.42
1.0
1.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
108
984
1.10
0.42
4.6
3.3
mg/l
28.9
27.0
0.21
83
613
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
824
8490
0.97
0.42
2.8
3.1
ug/l
0.8
0.8
0.06
565
5728
(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
0.2
—
0
6
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
16
0.00
0.41
0.0
1.2
—
3.4
—
0
16
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3015665) Acarus siro IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.0
—
0.1
—
0
7
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
58
511
1.14
0.40
1.1
1.2
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
8
60
1.33
0.40
4.1
2.3
pmol/l
106.1
72.5
—
8
55
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
16
205
0.78
0.40
1.3
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
104
1137
0.91
0.39
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
104
1137
0.91
0.39
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
104
1136
0.91
0.39
1.5
1.4
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
12
89
1.35
0.37
1.2
1.2
mmol/l
1.7
1.6
—
7
60
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
104
1133
0.92
0.37
1.5
1.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
33
281
1.18
0.36
1.0
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
122
1317
0.92
0.36
1.4
1.5
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
6
43
1.40
0.35
1.0
1.1
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
30
255
1.18
0.34
14.0
11.6
mmol/l
0.6
0.6
0.22
30
233
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
11
82
1.34
0.34
2.1
1.5
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
6
45
1.33
0.33
2.3
2.5
u/field
0.0
0.7
—
6
45
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
46
407
1.13
0.32
1.3
1.3
nmol/l
1.6
1.5
0.30
40
367
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
13
101
1.29
0.31
1.3
2.9
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
230
2414
0.95
0.31
2.1
1.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
516
5318
0.97
0.30
4.3
4.4
%
30.9
32.4
2.28
387
3613
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
62
565
1.10
0.28
1.2
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
168
1593
1.06
0.27
1.8
1.9
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
86
927
0.93
0.27
1.5
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
86
925
0.93
0.26
1.6
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
87
809
1.08
0.26
1.9
1.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
114
1071
1.07
0.26
1.9
1.9
iu/l
3.9
4.7
0.40
46
378
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
89
955
0.93
0.25
1.2
1.1
u/ml
0.8
1.6
1.00
45
421
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
19
160
1.19
0.25
1.2
1.3
g/l
0.3
0.3
0.74
12
130
(4146454)
42
466
0.90
0.25
3.0
2.7
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
6
84
0.71
0.24
1.0
1.0
mu/l
8.2
9.4
—
6
72
(3008898) HLA-B27 [Presence]
161
1535
1.05
0.23
1.1
1.1
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
20
171
1.17
0.23
2.5
2.3
nmol/l
176.1
151.1
0.26
14
146
(3016273) Islet cell 512 Ab [Units/volume] in Serum
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
32
285
1.12
0.22
1.1
1.2
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
5
40
1.25
0.22
1.2
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
107
1.22
0.21
1.0
1.1
—
—
—
0
0
(3026820) Hemoglobin [Mass/volume] in Venous cord blood
0
11
0.00
0.21
0.0
1.0
—
165.0
—
0
11
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3017958) Strawberry IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
0.0
—
0
5
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
4142
41244
1.02
0.21
4.3
3.8
mmol/l
1.3
1.3
4.63
3822
37760
(3014133) Dog dander IgE Ab [Units/volume] in Serum
60
647
0.93
0.21
1.1
1.1
u/ml
0.9
4.4
5.46
23
269
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
4254
42708
0.98
0.21
4.6
4.2
mmol/l
1.4
1.4
22.32
3928
39359
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
8
104
0.77
0.21
1.0
1.3
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
6
52
1.15
0.19
1.0
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
6
52
1.15
0.19
1.0
1.1
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
31
280
1.11
0.18
1.0
1.1
u/ml
1.9
2.5
0.18
14
87
(3008401) Mugwort IgE Ab [Units/volume] in Serum
78
826
0.94
0.18
1.1
1.1
u/ml
0.9
1.2
0.19
35
385
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
7
60
1.17
0.17
1.3
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
90
948
0.95
0.17
1.6
1.5
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
5
66
0.76
0.17
2.0
1.1
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
5
66
0.76
0.17
1.0
1.1
ug/l
60.3
72.1
—
5
54
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
8
69
1.16
0.16
1.8
1.2
—
—
—
0
0
(4024509)
40
432
0.93
0.16
1.9
1.6
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
19
168
1.13
0.15
2.0
1.6
—
—
—
0
0
(3006598) pH of Arterial cord blood
6
76
0.79
0.15
1.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
6
78
0.77
0.15
8.5
7.6
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
29
264
1.10
0.15
1.0
1.1
nmol/l
2.7
8.8
—
10
53
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
36
332
1.08
0.15
1.7
1.6
mmol/l
7.4
7.7
0.48
27
204
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1139
11273
1.01
0.14
1.8
1.6
mmol/l
1.4
1.4
1.09
970
9517
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
10
117
0.85
0.13
4.8
5.8
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
10
117
0.85
0.13
2.4
2.9
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
22
242
0.91
0.13
1.5
1.4
mmol/l
5.4
5.8
1.31
22
231
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
119
1229
0.97
0.11
1.5
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
4294
43038
0.99
0.11
4.7
4.3
mmol/l
4.4
4.6
33.69
3986
39892
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
12
105
1.14
0.11
1.3
1.1
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
28
260
1.08
0.10
1.8
2.1
ug/l
2.1
2.2
0.14
23
221
(3042517) Benzodiazepines panel - Urine
5
45
1.11
0.09
1.2
2.7
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
45
1.11
0.09
1.2
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
5
48
1.04
0.09
1.0
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
81
783
1.03
0.09
1.1
1.1
u/ml
0.4
2.2
4.88
17
210
(46235168) Fasting glucose [Moles/volume] in Blood
6
54
1.11
0.09
1.2
1.5
mmol/l
7.0
8.8
—
6
25
(3037556) Urate [Mass/volume] in Serum or Plasma
12
134
0.90
0.08
1.3
1.4
—
—
—
0
0
(4034850)
145
1418
1.02
0.08
17.4
9.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
491
4859
1.01
0.08
1.7
1.7
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
28
297
0.94
0.08
1.1
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
6
72
0.83
0.07
1.2
1.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
8
74
1.08
0.07
3.8
6.6
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
75
730
1.03
0.06
1.1
1.1
iu/ml
157.7
785.6
0.43
17
178
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
56
544
1.03
0.05
2.0
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
544
5404
1.01
0.05
2.3
2.1
—
—
—
0
0
(4133840)
10
110
0.91
0.05
1.1
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
12
111
1.08
0.04
2.3
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
485
4875
0.99
0.03
2.2
2.0
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
37
359
1.03
0.03
1.6
2.2
mmol/l
6.3
6.5
0.21
29
247
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
25
260
0.96
0.03
6.3
6.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
140
1385
1.01
0.03
1.4
1.4
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
30
291
1.03
0.02
1.2
1.5
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
60
590
1.02
0.02
1.1
1.1
u/ml
6.2
4.7
0.15
23
263
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
662
6602
1.00
0.02
1.6
1.4
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
28
288
0.97
0.02
1.1
1.1
u/ml
5.9
2.6
0.27
14
105
(3050129) First trimester maternal screen panel - Serum or Plasma
140
1390
1.01
0.01
1.4
1.4
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
26
253
1.03
0.01
1.0
1.1
u/ml
0.2
2.7
—
7
40
(3003888) Timothy IgE Ab [Units/volume] in Serum
85
858
0.99
0.01
1.1
1.1
u/ml
8.6
5.2
0.35
50
474
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
55
544
1.01
0.00
1.5
1.3
nmol/l
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
20
198
1.01
0.00
1.4
2.0
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
19
185
1.03
0.00
1.1
1.1
u/ml
2.4
6.8
—
7
32
(40768793) Breast Pathology biopsy report
90
897
1.00
0.00
1.3
1.3
—
—
—
0
0
(3032333) Phosphate [Mass or Moles] in 24 hour Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.1
—
115.5
—
0
8
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
5
51
0.98
0.00
8.0
8.9
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.7
—
0.2
—
0
6
(3007919) Fasciola sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002814) Trichinella spiralis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
6
66
0.91
0.00
1.0
1.0
—
—
—
0
0
(3005067) clonazePAM [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
51.3
—
0
5
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
8
86
0.93
0.00
2.3
2.1
umol/l
19.6
17.1
—
8
86
Mortality – FinRegistry
↥Association
Association between endpoint D3_PURPURA_AND3_OTHER_HAEMORRHAGIC and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_PURPURA_AND3_OTHER_HAEMORRHAGIC | 2.514 [2.28, 2.78] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.05 |
During the follow-up period (1.1.1998 — 31.12.2019), 4584 out of 16026 females with D3_PURPURA_AND3_OTHER_HAEMORRHAGIC died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_PURPURA_AND3_OTHER_HAEMORRHAGIC | 2.862 [2.55, 3.21] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 5559 out of 16338 males with D3_PURPURA_AND3_OTHER_HAEMORRHAGIC died.
Mortality risk
Mortality risk for people of age
years, who have D3_PURPURA_AND3_OTHER_HAEMORRHAGIC.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.2% | 0.642% |
| 5 | 1.373% | 3.25% |
| 10 | 3.513% | 7.796% |
| 15 | 6.314% | 13.524% |
| 20 | 10.521% | 22.98% |
Relationships between endpoints
↥Index endpoint: D3_PURPURA_AND3_OTHER_HAEMORRHAGIC – Purpura and other haemorrhagic conditions
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data